{"meta":{"page":1,"per_page":50,"max_per_page":100,"total":80,"total_is_capped":false,"direct_labels_cover":0,"predictions_cover":80,"direct_label_status":"direct model label, unvalidated","prediction_status":"machine_predicted_unvalidated (Codex and Gemma teacher distillation)","score_status":"score_only:v0-immature-baseline (scores rank; they never assert a category)","snapshot":{"source":"OpenAlex, pinned release, all 482 partitions","release":"2026-06-24","frame_built":"2026-07-12"},"query_hash":"11ddc1b80af9","filters":{"venue":"Diabetes Therapy"}},"results":[{"id":"W3044377510","doi":"10.1007/s13300-020-00884-0","title":"Burden of Diabetes and Prediabetes in Nepal: A Systematic Review and Meta-Analysis","year":2020,"lang":"en","type":"review","venue":"Diabetes Therapy","topic":"Diabetes, Cardiovascular Risks, and Lipoproteins","field":"Medicine","cited_by":90,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"","funders":"","keywords":"Prediabetes; Medicine; Diabetes mellitus; Meta-analysis; Intensive care medicine; Systematic review; MEDLINE; Traditional medicine; Type 2 diabetes; Internal medicine; Endocrinology","retraction":null,"screen_n_in":null,"score":{"opus":0.05304638649614409,"gpt":0.3116499172448164,"spread":0.2586035307486723,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","metaepi_broad"],"consensus_categories":[],"category_scores_codex":[0.001894888,0.001109105,0.02672034,0.000839209,0.00004616175,0.0000724248,0.0003797233,0.0004296771,0.0001284405],"category_scores_gemma":[0.0005217306,0.0007308273,0.00587165,0.002009177,0.0002536944,0.0001289246,0.0001529889,0.0005767765,0.00001152391],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00005359225,"about_ca_system_score_gemma":0.0001308672,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00009666734,"about_ca_topic_score_gemma":0.00001202287,"domain_scores_codex":[0.994302,0.001145357,0.002122748,0.001100379,0.0006646388,0.000664871],"domain_scores_gemma":[0.9963011,0.0007520508,0.0010189,0.001413261,0.0001607821,0.000353886],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","study_design_scores_codex":[0.000001252879,0.00004821562,0.00006483617,0.6231855,0.2477658,0.000005381753,0.00009554813,1.764815e-7,6.177262e-7,0.000003835823,0.00002975046,0.1287991],"study_design_scores_gemma":[0.0005789764,0.0002996557,0.00006037548,0.06451569,0.8781288,0.000002171757,0.00001859143,0.00002410951,0.00001138982,0.0000312708,0.05570464,0.0006243051],"study_design_candidate":"meta_analysis","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0005672956,0.9911522,9.998718e-7,0.0002222868,0.00002918151,0.007651142,0.0002391014,0.00007818382,0.0000595567],"genre_scores_gemma":[0.0003318731,0.9959413,0.0001910063,0.0006286771,0.00009562859,0.002367708,0.000200681,0.0001518748,0.00009125483],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.630363,"threshold_uncertainty_score":0.9995143,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2914739803","doi":"10.1007/s13300-019-0568-8","title":"Rates of Hypoglycemia Predicted in Patients with Type 2 Diabetes on Insulin Glargine 300 U/ml Versus First- and Second-Generation Basal Insulin Analogs: The Real-World LIGHTNING Study","year":2019,"lang":"en","type":"article","venue":"Diabetes Therapy","topic":"Diabetes Management and Research","field":"Medicine","cited_by":65,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Lawson Health Research Institute; Western University","funders":"Sanofi","keywords":"Medicine; Insulin glargine; Insulin degludec; Insulin detemir; Hypoglycemia; Insulin; Type 2 diabetes; Diabetes mellitus; Internal medicine; Basal (medicine); Basal insulin; Endocrinology","retraction":null,"screen_n_in":null,"score":{"opus":0.02118217410258335,"gpt":0.2726222910436291,"spread":0.2514401169410458,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005441498,0.0002678295,0.0004913834,0.0004267811,0.00008947874,0.00005451959,0.0001905404,0.00007805093,0.0002485178],"category_scores_gemma":[0.00007724142,0.0001636658,0.00004317416,0.0009574551,0.0001043504,0.0001553143,0.0000711512,0.0003130178,0.00001474729],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00006208035,"about_ca_system_score_gemma":0.00004819792,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00001955695,"about_ca_topic_score_gemma":0.0002008959,"domain_scores_codex":[0.9980797,0.0001738519,0.0003744535,0.0004181384,0.0005219731,0.00043193],"domain_scores_gemma":[0.9987173,0.0003687296,0.0001543658,0.0004703509,0.0002048077,0.00008443544],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.002210964,0.001020506,0.9870757,0.00007856529,0.00042117,0.000001308945,0.0004983681,0.00007738089,0.0009683419,0.00002402826,0.000228561,0.007395098],"study_design_scores_gemma":[0.01706453,0.009466986,0.9676042,0.0001525609,0.00004565205,3.715653e-9,0.0001064912,0.001996803,0.002849638,0.00001661394,0.0005157106,0.0001807741],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9960349,0.0004901947,1.031953e-7,0.0002320967,0.0002297645,0.002017322,0.00001732231,0.00003669781,0.0009416316],"genre_scores_gemma":[0.9987866,0.0001977609,0.00002725648,0.0002136796,0.0001091169,0.00006772899,0.0002059185,0.00004624217,0.0003457386],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.01947147,"threshold_uncertainty_score":0.6674097,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2899457817","doi":"10.1007/s13300-018-0524-z","title":"Liraglutide and Glycaemic Outcomes in the LEADER Trial","year":2018,"lang":"en","type":"article","venue":"Diabetes Therapy","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":50,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Toronto; Lunenfeld-Tanenbaum Research Institute","funders":"Novo Nordisk","keywords":"Liraglutide; Medicine; Diabetes mellitus; Intensive care medicine; Empagliflozin; Internal medicine; Type 2 diabetes; Endocrinology","retraction":null,"screen_n_in":null,"score":{"opus":0.03176115977629661,"gpt":0.2979267338069327,"spread":0.2661655740306361,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002582177,0.0001377815,0.0002481618,0.00008703854,0.00005070081,0.0000335411,0.00009466316,0.00004300754,0.00009316707],"category_scores_gemma":[0.00002467511,0.00007582711,0.00006368321,0.0001284096,0.0001314898,0.00005853167,0.00001953787,0.00007762419,0.00005315642],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00001844482,"about_ca_system_score_gemma":0.00001085032,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000008391126,"about_ca_topic_score_gemma":0.000008986557,"domain_scores_codex":[0.9991868,0.00004889327,0.0001507486,0.0001842624,0.0001575883,0.0002716784],"domain_scores_gemma":[0.999525,0.0001123537,0.00003347538,0.0002731356,0.00001832131,0.00003777347],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.003015542,0.0009346011,0.8334858,0.00002419101,0.0004500618,0.000012435,0.00230285,7.910523e-8,0.001430192,0.0008816285,0.004804402,0.1526582],"study_design_scores_gemma":[0.1081504,0.005785974,0.7875007,0.00006608874,0.0001375431,9.555135e-7,0.0004185856,0.00004996944,0.004022895,0.001392318,0.09217886,0.0002956737],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9905303,0.0008653353,0.000001160426,0.00388916,0.0001825975,0.0009066134,0.000001430743,0.00003842634,0.003585003],"genre_scores_gemma":[0.9920018,0.0002158313,0.00007804623,0.006272835,0.0002453431,0.0001110756,0.000008644144,0.00001506662,0.001051408],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1523625,"threshold_uncertainty_score":0.309214,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2041650397","doi":"10.1007/s13300-014-0065-z","title":"Early Discontinuation and Restart of Insulin in the Treatment of Type 2 Diabetes Mellitus","year":2014,"lang":"en","type":"article","venue":"Diabetes Therapy","topic":"Diabetes Management and Research","field":"Medicine","cited_by":50,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Eli Lilly (Canada)","funders":"Eli Lilly and Company","keywords":"Medicine; Discontinuation; Diabetes mellitus; Insulin; Type 2 Diabetes Mellitus; Type 2 diabetes; Internal medicine; Intensive care medicine; Endocrinology","retraction":null,"screen_n_in":null,"score":{"opus":0.02251598766230535,"gpt":0.2845708432846278,"spread":0.2620548556223224,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004828351,0.0001003168,0.0002857535,0.0001390776,0.00001971656,0.00001362805,0.00008441856,0.00004088517,0.00002284278],"category_scores_gemma":[0.00004395032,0.00005691954,0.00005069776,0.0002588314,0.0001292799,0.00005112384,0.00001003598,0.00004963014,0.000003498116],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00001145751,"about_ca_system_score_gemma":0.00001089218,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00001510637,"about_ca_topic_score_gemma":0.000004796716,"domain_scores_codex":[0.9990979,0.000131222,0.0002138118,0.0001381393,0.000217787,0.0002011651],"domain_scores_gemma":[0.9993376,0.0002413498,0.00006989639,0.0002640827,0.00006072292,0.00002636399],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.00008721986,0.0006928891,0.5796788,0.00005459665,0.00009324087,3.483395e-7,0.001484572,0.000002229475,0.008291921,0.0004085479,0.00004493475,0.4091608],"study_design_scores_gemma":[0.002776565,0.005873096,0.9616976,0.00009409731,0.00003431234,1.432576e-8,0.00009483172,0.0007076017,0.0193829,0.0009969397,0.008261249,0.00008079183],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9922745,0.005877574,0.000001127764,0.0005087539,0.00004072339,0.0004954317,0.000002285539,0.000008003193,0.0007915662],"genre_scores_gemma":[0.9967505,0.002819948,0.00007027169,0.0000898049,0.00005075333,0.00002782833,0.00001891047,0.00001114636,0.0001608213],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.40908,"threshold_uncertainty_score":0.2321111,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2023859994","doi":"10.1007/s13300-012-0013-8","title":"Efficacy and Safety of Taspoglutide Versus Sitagliptin for Type 2 Diabetes Mellitus (T-Emerge 4 Trial)","year":2012,"lang":"en","type":"article","venue":"Diabetes Therapy","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":47,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Centre Hospitalier de l’Université de Montréal","funders":"F. Hoffmann-La Roche","keywords":"Sitagliptin; Medicine; Placebo; Metformin; Internal medicine; Sitagliptin Phosphate; Clinical endpoint; Gastroenterology; Diabetes mellitus; Type 2 diabetes; Randomized controlled trial; Endocrinology","retraction":null,"screen_n_in":null,"score":{"opus":0.04398356113229868,"gpt":0.3092227144635877,"spread":0.265239153331289,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000447934,0.000258314,0.0005708796,0.0001234944,0.00007234207,0.0000134185,0.00009252183,0.00009089933,0.0001733905],"category_scores_gemma":[0.0001225197,0.0002058341,0.0001575606,0.0002015773,0.00009462101,0.0001319562,0.00003970172,0.00006902263,0.00002387014],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00004258007,"about_ca_system_score_gemma":0.00002092542,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000002085446,"about_ca_topic_score_gemma":6.011277e-7,"domain_scores_codex":[0.9985336,0.00004756233,0.0003578641,0.0002517909,0.0001950375,0.0006141401],"domain_scores_gemma":[0.9987419,0.0004757889,0.0001405742,0.0003641955,0.00008691131,0.000190667],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.1195828,0.004976739,0.141864,0.0006468797,0.006240793,0.000001296413,0.001216114,0.000004481414,0.03115904,0.005908486,0.006702619,0.6816967],"study_design_scores_gemma":[0.3747845,0.01723647,0.1089303,0.0002472994,0.001618644,1.281618e-7,0.0001948544,0.0001253434,0.1046555,0.0003073143,0.3910507,0.0008489158],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9734017,0.02204691,0.000006574674,0.0002879291,0.0008951866,0.002131567,0.00002453139,0.0000624089,0.001143245],"genre_scores_gemma":[0.9947937,0.00282536,0.0009601597,0.0002656555,0.0003658825,0.0001577643,0.0001398663,0.00005077438,0.0004408507],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.6808478,"threshold_uncertainty_score":0.8393672,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3114726363","doi":"10.1007/s13300-020-00984-x","title":"Real-World Effectiveness Analysis of Switching From Liraglutide or Dulaglutide to Semaglutide in Patients With Type 2 Diabetes Mellitus: The Retrospective REALISE-DM Study","year":2020,"lang":"en","type":"article","venue":"Diabetes Therapy","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":46,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"Fraser Health; University of British Columbia","funders":"Novo Nordisk Canada; Novo Nordisk","keywords":"Semaglutide; Dulaglutide; Liraglutide; Medicine; Internal medicine; Tolerability; Type 2 diabetes; Interquartile range; Body mass index; Exenatide; Glycated hemoglobin; Gastroenterology; Type 2 Diabetes Mellitus; Endocrinology; Diabetes mellitus; Adverse effect","retraction":null,"screen_n_in":null,"score":{"opus":0.01455503054483066,"gpt":0.2668258907390139,"spread":0.2522708601941833,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0005607403,0.0004769517,0.001464458,0.0005793874,0.0001026659,0.00005367203,0.000332887,0.00006027727,0.000103709],"category_scores_gemma":[0.0001976606,0.0002791859,0.0002203136,0.004530461,0.00006783408,0.0001232493,0.0001289513,0.0002448932,0.00001412557],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002784155,"about_ca_system_score_gemma":0.00006060282,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0009318514,"about_ca_topic_score_gemma":0.001142374,"domain_scores_codex":[0.9969065,0.0004098385,0.000584651,0.0008092973,0.000694301,0.0005953793],"domain_scores_gemma":[0.9976922,0.0007469126,0.0002624776,0.000822165,0.0002435736,0.000232625],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.002373225,0.00139307,0.9787599,0.0000492561,0.007636328,0.00001140763,0.002827686,0.0003852452,0.0009102328,0.00002908463,0.00006686936,0.005557674],"study_design_scores_gemma":[0.005629833,0.005057224,0.9821705,0.0002007084,0.002283269,4.323327e-9,0.000380075,0.0003769605,0.003392709,0.0000593896,0.0001375074,0.000311867],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9954256,0.0003062523,0.00001017205,0.0004004154,0.00008654619,0.003330173,0.00006979,0.0001076564,0.0002633759],"genre_scores_gemma":[0.9980778,0.00007439258,0.0001946429,0.001071603,0.00007149755,0.0002200047,0.0001687707,0.00007634191,0.00004498942],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.005353059,"threshold_uncertainty_score":0.999966,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2567557402","doi":"10.1007/s13300-016-0220-9","title":"Lack of Evidence to Guide Deprescribing of Antihyperglycemics: A Systematic Review","year":2016,"lang":"en","type":"review","venue":"Diabetes Therapy","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":46,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"Public Health Ontario; University of Waterloo; Women's College Hospital; University of Toronto; Ottawa Hospital; University of Ottawa; Bruyère","funders":"Canadian Institutes of Health Research","keywords":"Deprescribing; Medicine; MEDLINE; Type 2 diabetes; Glycemic; Cochrane Library; Hypoglycemia; CINAHL; Glycated hemoglobin; Polypharmacy; Adverse effect; Intensive care medicine; Systematic review; Diabetes mellitus; Meta-analysis; Nursing; Internal medicine; Psychological intervention","retraction":null,"screen_n_in":null,"score":{"opus":0.233773798645742,"gpt":0.4214522913955017,"spread":0.1876784927497597,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0008969132,0.000522556,0.005907736,0.0003270438,0.00001838437,0.00001052329,0.0004710613,0.0001362112,0.0001077228],"category_scores_gemma":[0.0006152964,0.0002657404,0.001030483,0.0005005852,0.00006076007,0.00008491188,0.0001218875,0.0000981795,0.0001136905],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001363844,"about_ca_system_score_gemma":0.0001500855,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000003885957,"about_ca_topic_score_gemma":2.611682e-7,"domain_scores_codex":[0.9966861,0.0002368376,0.001748138,0.0004650762,0.0004748081,0.0003890492],"domain_scores_gemma":[0.9965932,0.0006224626,0.001020453,0.001390438,0.0002324211,0.0001410625],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","study_design_scores_codex":[0.000005763683,0.00008132037,0.00005689526,0.6755111,0.001335812,0.000002846426,0.00001670246,1.446547e-8,0.00003300647,0.00002342137,0.001193008,0.3217401],"study_design_scores_gemma":[0.0002823477,0.0003832141,0.000002291674,0.7316428,0.00388037,9.858455e-7,0.000002284503,2.789864e-7,0.0000946083,0.000006052077,0.2635155,0.0001892081],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.00007403831,0.9919876,0.000009436907,0.0001203018,0.0001191738,0.007092545,0.00003429743,0.00004462588,0.0005179492],"genre_scores_gemma":[0.0000223364,0.9964542,0.0003352052,0.0007669455,0.00005822891,0.0007357086,0.00002967988,0.00008417594,0.001513564],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.3215509,"threshold_uncertainty_score":0.9999795,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2276028032","doi":"10.1007/s13300-016-0155-1","title":"A Network Meta-analysis Comparing Exenatide Once Weekly with Other GLP-1 Receptor Agonists for the Treatment of Type 2 Diabetes Mellitus","year":2016,"lang":"en","type":"review","venue":"Diabetes Therapy","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":43,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Sheridan College; Public Health Ontario","funders":"AstraZeneca","keywords":"Exenatide; Medicine; Lixisenatide; Tolerability; Dulaglutide; Metformin; Liraglutide; Internal medicine; Type 2 diabetes; Glycated hemoglobin; Glucagon-like peptide 1 receptor; Discontinuation; Type 2 Diabetes Mellitus; Pharmacology; Diabetes mellitus; Adverse effect; Endocrinology; Agonist; Insulin; Receptor","retraction":null,"screen_n_in":null,"score":{"opus":0.1266099849112865,"gpt":0.3423086737592977,"spread":0.2156986888480112,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0004827387,0.001027787,0.006902353,0.0002974551,0.0001681099,0.00007770387,0.0004165078,0.0001957414,0.0005401105],"category_scores_gemma":[0.00001963047,0.0004282487,0.003826806,0.001056228,0.0002083142,0.00007098506,0.00003605945,0.0001120526,0.00005091804],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002525605,"about_ca_system_score_gemma":0.0001223445,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00001528733,"about_ca_topic_score_gemma":0.00001486801,"domain_scores_codex":[0.9967387,0.0002268794,0.0009062012,0.0008026499,0.0004472191,0.0008783922],"domain_scores_gemma":[0.9954019,0.00189546,0.000917087,0.001423662,0.0002070404,0.0001548579],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00008178982,0.0005275646,0.001012529,0.001149434,0.4135447,8.480332e-7,0.00006660178,0.0000166205,0.000002200112,0.0001255579,0.0009406808,0.5825315],"study_design_scores_gemma":[0.001157904,0.002011941,0.00003259459,0.001007339,0.2780427,6.641645e-8,0.000006473443,0.00002382815,0.00005415939,0.0000349348,0.7172894,0.0003385987],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0004982382,0.9933073,0.00006741416,0.0003117786,0.0002174646,0.004975562,0.0001745078,0.000087596,0.0003601637],"genre_scores_gemma":[0.000261106,0.9898666,0.001300208,0.0002788774,0.0004175616,0.003257936,0.0004515538,0.0001841869,0.003982008],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.7163488,"threshold_uncertainty_score":0.999817,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2942132427","doi":"10.1007/s13300-019-0615-5","title":"GLP-1 RA Treatment and Dosing Patterns Among Type 2 Diabetes Patients in Six Countries: A Retrospective Analysis of Pharmacy Claims Data","year":2019,"lang":"en","type":"article","venue":"Diabetes Therapy","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":41,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"","funders":"Eli Lilly and Company","keywords":"Medicine; Discontinuation; Exenatide; Type 2 diabetes; Liraglutide; Dulaglutide; Internal medicine; Retrospective cohort study; Dosing; Lira; Pharmacy; Diabetes mellitus; Family medicine; Endocrinology","retraction":null,"screen_n_in":null,"score":{"opus":0.01924185101910407,"gpt":0.2880518748939809,"spread":0.2688100238748768,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001952171,0.0002971935,0.0008616305,0.0004853251,0.00003474675,0.00004261471,0.0001723541,0.00005678312,0.0003116853],"category_scores_gemma":[0.00001243781,0.0002308688,0.0001148446,0.0007182014,0.00007822416,0.0002720214,0.00008117856,0.0000707691,0.00001029017],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002081419,"about_ca_system_score_gemma":0.00002467389,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001565569,"about_ca_topic_score_gemma":0.0001183508,"domain_scores_codex":[0.9983281,0.00006007796,0.0003625784,0.0005699912,0.0002673167,0.0004119411],"domain_scores_gemma":[0.9987233,0.0001199404,0.0001827295,0.0007725559,0.000104453,0.00009703264],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0001169596,0.0009436613,0.9790173,0.00006742062,0.004029832,0.000001791117,0.0005845677,0.000007531227,0.0004164533,0.00001117555,0.00004544384,0.01475789],"study_design_scores_gemma":[0.007396244,0.001457672,0.9814804,0.0001083961,0.001382044,8.9392e-9,0.00006605699,0.003020661,0.00317504,0.00001468632,0.001696768,0.0002020902],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9968725,0.001289469,7.608172e-7,0.0000633579,0.0001505608,0.00115964,0.0002200609,0.00003748647,0.0002061994],"genre_scores_gemma":[0.9942459,0.003907828,0.00003527272,0.0002293753,0.00003197281,0.00004204978,0.001330721,0.00003389147,0.0001430018],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.0145558,"threshold_uncertainty_score":0.9414557,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2589084718","doi":"10.1007/s13300-017-0232-0","title":"Effects of Canagliflozin on Serum Magnesium in Patients With Type 2 Diabetes Mellitus: A Post Hoc Analysis of Randomized Controlled Trials","year":2017,"lang":"en","type":"article","venue":"Diabetes Therapy","topic":"Magnesium in Health and Disease","field":"Nursing","cited_by":40,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Toronto; St. Michael's Hospital","funders":"European Association for the Study of Diabetes; Mitsubishi Tanabe Pharma Corporation; Canada Research Chairs; European Foundation for the Study of Diabetes; AstraZeneca; Janssen Scientific Affairs; American Diabetes Association","keywords":"Canagliflozin; Medicine; Post-hoc analysis; Internal medicine; Magnesium; Placebo; Gastroenterology; Diabetes mellitus; Type 2 diabetes; Endocrinology; Type 2 Diabetes Mellitus; Randomized controlled trial; Hypermagnesemia; Hypomagnesemia; Chemistry; Pathology","retraction":null,"screen_n_in":null,"score":{"opus":0.008613324038143825,"gpt":0.2704837260594343,"spread":0.2618704020212905,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003139486,0.0003450303,0.005267815,0.0007522661,0.0001210926,0.00005753315,0.0003634001,0.000130472,0.0001386649],"category_scores_gemma":[0.005464407,0.0002157231,0.0008134099,0.0004374827,0.0002171736,0.0001277309,0.00001943454,0.0001146482,0.000002526527],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00004327897,"about_ca_system_score_gemma":0.00008255602,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0003792584,"about_ca_topic_score_gemma":0.0001121143,"domain_scores_codex":[0.9952922,0.001977994,0.001355959,0.0003593018,0.000501045,0.000513498],"domain_scores_gemma":[0.9914801,0.005333157,0.001783996,0.000779476,0.0004324509,0.0001908139],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.4763906,0.0009043059,0.5054821,0.0007203542,0.001401477,0.000001071716,0.0002715585,0.00005335257,0.001081645,0.00002639391,0.0000152702,0.01365186],"study_design_scores_gemma":[0.3995424,0.002544186,0.5838125,0.0001033821,0.003299794,1.642091e-9,0.00001454313,0.0005770743,0.009768587,0.00009819533,0.000006582315,0.0002327365],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9888765,0.006022846,3.867983e-7,0.000300362,0.0005479448,0.003974505,0.0001118657,0.00002219319,0.0001434351],"genre_scores_gemma":[0.9988233,0.00007742085,0.00003247684,0.0006345559,0.00005576563,0.000264885,0.00006043867,0.00003311805,0.0000180504],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.07833037,"threshold_uncertainty_score":0.8796933,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2129617225","doi":"10.1007/s13300-015-0118-y","title":"Associations Between Glycemic Control, Depressed Mood, Clinical Depression, and Diabetes Distress Before and After Insulin Initiation: An Exploratory, Post Hoc Analysis","year":2015,"lang":"en","type":"article","venue":"Diabetes Therapy","topic":"Diabetes Management and Education","field":"Medicine","cited_by":39,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Eli Lilly (Canada)","funders":"Eli Lilly and Company","keywords":"Medicine; Glycemic; Depression (economics); Distress; Internal medicine; Diabetes mellitus; Glycated hemoglobin; Observational study; Type 2 diabetes; Confounding; Mood; Post-hoc analysis; Patient Health Questionnaire; Psychiatry; Insulin; Endocrinology; Clinical psychology; Depressive symptoms","retraction":null,"screen_n_in":null,"score":{"opus":0.02949611979113506,"gpt":0.3126876059710592,"spread":0.2831914861799241,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007847912,0.000271067,0.0007339675,0.0002829707,0.0001238946,0.0001650317,0.0001260096,0.0002023569,0.0000338849],"category_scores_gemma":[0.0002516936,0.0002325418,0.0001339521,0.0004713558,0.0001552068,0.0006060392,0.00005539332,0.0002065249,0.000009685947],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00004762875,"about_ca_system_score_gemma":0.00005899515,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000007467852,"about_ca_topic_score_gemma":0.00005369053,"domain_scores_codex":[0.9979146,0.0002678407,0.000573418,0.0005201564,0.0003299617,0.0003940246],"domain_scores_gemma":[0.998163,0.0002839379,0.0002710865,0.0004500929,0.0003543397,0.0004775542],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0002463236,0.0002647316,0.9663578,0.00001725667,0.001169012,8.565453e-7,0.0008065513,0.000003271323,0.00005618185,0.000006600913,0.000145396,0.03092606],"study_design_scores_gemma":[0.005578457,0.001093593,0.9901928,0.00003704167,0.001251987,4.745553e-8,0.0002149384,0.0005871567,0.0001323879,0.0003558628,0.0003174561,0.0002382625],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9955198,0.002355566,0.00003185982,0.00095003,0.0001562471,0.0005160261,0.0002780308,0.0001082999,0.00008413578],"genre_scores_gemma":[0.9955547,0.000236772,0.0001627393,0.001311301,0.0005323509,0.000152414,0.001983367,0.00003976395,0.00002653739],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.0306878,"threshold_uncertainty_score":0.948278,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2982342400","doi":"10.1007/s13300-019-00715-x","title":"Glomerular Filtration Rate and Associated Risks ofCardiovascular Events, Mortality, and Severe Hypoglycemia in Patients with Type 2 Diabetes:Secondary Analysis (DEVOTE 11)","year":2019,"lang":"en","type":"article","venue":"Diabetes Therapy","topic":"Chronic Kidney Disease and Diabetes","field":"Medicine","cited_by":38,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Lunenfeld-Tanenbaum Research Institute; University of Toronto","funders":"National Center for Advancing Translational Sciences; National Institute of Diabetes and Digestive and Kidney Diseases; Janssen Research and Development; National Institutes of Health; Novo Nordisk; European Association for the Study of Diabetes; Zafgen; Eli Lilly and Company; AstraZeneca; CSL Behring; Merck Sharp and Dohme; Eisai; Sanofi; MannKind Corporation; GlaxoSmithKline; Pfizer","keywords":"Medicine; Hypoglycemia; Diabetes mellitus; Renal function; Type 2 diabetes; Type 1 diabetes; Intensive care medicine; Internal medicine; Endocrinology","retraction":null,"screen_n_in":null,"score":{"opus":0.01189887918085034,"gpt":0.2452931604264202,"spread":0.2333942812455699,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0004517647,0.0003058735,0.0008266606,0.0002522958,0.00005967411,0.00004471784,0.00007695376,0.0001660339,0.0003060109],"category_scores_gemma":[0.00008174271,0.0002524368,0.0001808067,0.0007425714,0.00007013193,0.0002021064,0.00003793388,0.000202925,0.0000140507],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001026504,"about_ca_system_score_gemma":0.000136341,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00007898965,"about_ca_topic_score_gemma":0.0000403395,"domain_scores_codex":[0.9981243,0.0001904366,0.0003194766,0.0005353741,0.0003761068,0.0004543063],"domain_scores_gemma":[0.998886,0.0001105906,0.0001399374,0.0004766437,0.0001511147,0.0002356649],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0001277759,0.0002354463,0.9913287,0.00009445235,0.003992248,0.000002654039,0.00007003597,0.00004176027,0.0004292467,0.000002437911,0.00006427259,0.003610986],"study_design_scores_gemma":[0.00976236,0.0005605604,0.9865193,0.0001212722,0.001191862,9.166941e-8,0.0000199282,0.0006186736,0.0005532741,0.00009043785,0.0002418606,0.0003204181],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9932672,0.005538098,6.83654e-7,0.00005140818,0.00006836945,0.000778188,0.00009959121,0.00004477827,0.0001516406],"genre_scores_gemma":[0.9975224,0.0005361963,0.00002332826,0.0006760562,0.00003187501,0.00002554047,0.001068229,0.00003726997,0.00007906715],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.009634584,"threshold_uncertainty_score":0.9999928,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4400789217","doi":"10.1007/s13300-024-01606-6","title":"Epidemiology and Burden of Peripheral Artery Disease in People With Type 2 Diabetes: A Systematic Literature Review","year":2024,"lang":"en","type":"review","venue":"Diabetes Therapy","topic":"Peripheral Artery Disease Management","field":"Medicine","cited_by":30,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Toronto; St. Michael's Hospital","funders":"Novo Nordisk","keywords":"Medicine; Epidemiology; Diabetes mellitus; Type 2 diabetes; Disease; Systematic review; Arterial disease; Intensive care medicine; MEDLINE; Internal medicine; Vascular disease; Endocrinology","retraction":null,"screen_n_in":null,"score":{"opus":0.0265531670890875,"gpt":0.3185727102160221,"spread":0.2920195431269346,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0007963106,0.0007414001,0.00548823,0.0003439188,0.00002411826,0.00002801456,0.0002287076,0.0001813948,0.00008658778],"category_scores_gemma":[0.0001981251,0.0004239748,0.0005177184,0.00102003,0.0001212094,0.00009036309,0.00008528851,0.0004544682,0.00002735205],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001380602,"about_ca_system_score_gemma":0.0001982623,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000002099312,"about_ca_topic_score_gemma":0.000002178208,"domain_scores_codex":[0.9963831,0.0007935541,0.001274042,0.000750714,0.0002509186,0.0005476822],"domain_scores_gemma":[0.9979832,0.0002962709,0.0004198971,0.0008861814,0.00009634841,0.0003180654],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","study_design_scores_codex":[0.00003108958,0.0001020271,0.002791429,0.94213,0.001141591,0.00009436681,0.0001812993,6.495033e-7,6.008735e-7,0.0000230468,0.000638828,0.0528651],"study_design_scores_gemma":[0.0004439614,0.0004531246,0.0006508393,0.9058013,0.00423652,0.00000881964,0.00001006898,0.0001157442,4.875061e-8,0.00004602603,0.08782452,0.000409013],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.003191709,0.9912832,4.158294e-7,0.0004005625,0.000143116,0.004788484,0.00007851419,0.00006835037,0.00004562066],"genre_scores_gemma":[0.0003824315,0.9955523,0.00005389395,0.001574685,0.0001608414,0.001359498,0.0004277568,0.0001161743,0.0003724085],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.08718569,"threshold_uncertainty_score":0.9998212,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W1974658403","doi":"10.1007/s13300-014-0080-0","title":"Cost–Utility Analysis of Glucagon-Like Peptide-1 Agonists Compared with Dipeptidyl Peptidase-4 Inhibitors or Neutral Protamine Hagedorn Basal Insulin as Add-On to Metformin in Type 2 Diabetes in Sweden","year":2014,"lang":"en","type":"article","venue":"Diabetes Therapy","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":29,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Institute of Health Economics","funders":"Lunds Universitet; Vetenskapsrådet; Novo Nordisk; Sanofi; Eli Lilly and Company","keywords":"Medicine; Metformin; Internal medicine; Endocrinology; Sitagliptin; Insulin; Type 2 Diabetes Mellitus; Diabetes mellitus","retraction":null,"screen_n_in":null,"score":{"opus":0.03225883259212647,"gpt":0.2965570996966915,"spread":0.2642982671045651,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0009351201,0.0006225133,0.001698494,0.00146851,0.00006612916,0.0000601955,0.0003253363,0.0001568814,0.0003356162],"category_scores_gemma":[0.0001605048,0.000444148,0.0002579096,0.003333891,0.0001730059,0.0001986039,0.00009222119,0.000312668,0.00006789309],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002297948,"about_ca_system_score_gemma":0.0001271284,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001926993,"about_ca_topic_score_gemma":0.001417972,"domain_scores_codex":[0.9964627,0.0002577788,0.0008851926,0.0008559962,0.0005732084,0.0009651295],"domain_scores_gemma":[0.9979162,0.0003917475,0.0002706709,0.0009092648,0.0001793702,0.0003327816],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.003822907,0.003137696,0.9273348,0.000200772,0.002212232,0.00003044305,0.001098152,0.000680137,0.004827523,0.00004697436,0.0008557166,0.05575258],"study_design_scores_gemma":[0.01090355,0.007989169,0.9021708,0.0006859748,0.0007313892,2.138249e-7,0.0003027758,0.003958364,0.0658451,0.00004834869,0.006684886,0.0006794079],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9947404,0.0002603598,0.000005128724,0.0003060376,0.0001324593,0.003253552,0.00003979142,0.0000929132,0.001169347],"genre_scores_gemma":[0.9961921,0.00008617916,0.0005523748,0.001302403,0.00007783391,0.0006550163,0.0004105305,0.00007630191,0.0006472605],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.06101758,"threshold_uncertainty_score":0.999801,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2172438155","doi":"10.1007/s13300-015-0142-y","title":"IDegLira Versus Alternative Intensification Strategies in Patients with Type 2 Diabetes Inadequately Controlled on Basal Insulin Therapy","year":2015,"lang":"en","type":"article","venue":"Diabetes Therapy","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":29,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Toronto","funders":"Novo Nordisk Fonden; Novo Nordisk","keywords":"Medicine; Liraglutide; Insulin glargine; Insulin degludec; Type 2 diabetes; Insulin aspart; Hypoglycemia; Internal medicine; Insulin; Glycated hemoglobin; Lixisenatide; Diabetes mellitus; Glucagon-like peptide 1 receptor; Endocrinology; Agonist","retraction":null,"screen_n_in":null,"score":{"opus":0.04309277245387194,"gpt":0.2779275746307542,"spread":0.2348348021768822,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0003072377,0.0003721329,0.0006674857,0.0003107257,0.00004116418,0.00008717973,0.0001599716,0.00009046396,0.00005168739],"category_scores_gemma":[0.00009933657,0.0002481084,0.00008298128,0.000402106,0.0001015918,0.0002798708,0.00002116282,0.0001855686,0.00007857943],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002030216,"about_ca_system_score_gemma":0.0001080106,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00001755466,"about_ca_topic_score_gemma":0.000007181575,"domain_scores_codex":[0.9981239,0.0001310689,0.0003461621,0.000423542,0.000499684,0.000475575],"domain_scores_gemma":[0.9986268,0.0001951119,0.0001832884,0.0004032145,0.0004333275,0.0001582569],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.06099921,0.005066849,0.7832755,0.00003373189,0.002942928,0.00001531926,0.002167415,0.0002604149,0.0008051876,0.001762157,0.001246303,0.141425],"study_design_scores_gemma":[0.2196291,0.03477958,0.728529,0.0002509574,0.0001193991,2.454983e-8,0.0008884807,0.0008863304,0.009328059,0.001579569,0.003307431,0.0007020453],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9927073,0.001041349,0.000002768639,0.0004783363,0.0004572293,0.001879362,0.000006624244,0.0000977759,0.003329284],"genre_scores_gemma":[0.9975644,0.0003317936,0.0001145962,0.00125605,0.0001022271,0.0002430443,0.0002271465,0.00005639366,0.0001043027],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1586299,"threshold_uncertainty_score":0.9999971,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3034312489","doi":"10.1007/s13300-020-00851-9","title":"The Effectiveness of Acceptance and Commitment Therapy on Pain Acceptance and Pain Perception in Patients with Painful Diabetic Neuropathy: A Randomized Controlled Trial","year":2020,"lang":"en","type":"article","venue":"Diabetes Therapy","topic":"Pain Mechanisms and Treatments","field":"Medicine","cited_by":28,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":true},"ca_institutions":"","funders":"Deputy for Research and Technology, Kermanshah University of Medical Sciences; Kermanshah University of Medical Sciences; Bausch Health; Ortho Dermatologics","keywords":"Acceptance and commitment therapy; Medicine; Physical therapy; Neuropathic pain; Randomized controlled trial; Intervention (counseling); McGill Pain Questionnaire; Clinical trial; Chronic pain; Diabetic neuropathy; Test (biology); Diabetes mellitus; Psychiatry; Surgery; Anesthesia; Internal medicine; Visual analogue scale","retraction":null,"screen_n_in":null,"score":{"opus":0.008025394181544177,"gpt":0.2279242926484802,"spread":0.219898898466936,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005696482,0.0003027597,0.0013206,0.00005897811,0.0001023069,0.00003853307,0.00008747275,0.00006958184,0.00001433868],"category_scores_gemma":[0.0007743102,0.0001553984,0.0001427861,0.0001605558,0.0001730556,0.00005993504,0.00001415245,0.0001548094,6.752626e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00003697836,"about_ca_system_score_gemma":0.00002555852,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000003612416,"about_ca_topic_score_gemma":0.000001318231,"domain_scores_codex":[0.992909,0.005738125,0.0004024208,0.0003604049,0.0003164865,0.0002735842],"domain_scores_gemma":[0.9936172,0.005743691,0.000218589,0.0002377125,0.00007594252,0.0001068191],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.7163401,0.0005372333,0.2000622,0.00003962831,0.0003201079,0.000002031562,0.0004155838,0.00000288188,0.0009683317,0.00004197951,0.000002815209,0.08126716],"study_design_scores_gemma":[0.6942725,0.008546488,0.2952137,0.0001483778,0.00004209176,3.316552e-8,0.00004282828,0.001026944,0.0004033351,0.0001741878,0.00001497438,0.0001146282],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9880952,0.001549621,0.0001329378,0.0003844692,0.00005591796,0.009726753,0.000005401858,0.00002779123,0.00002196557],"genre_scores_gemma":[0.9952896,0.001396609,0.00006400225,0.001792943,0.00003905941,0.001362134,0.00001617524,0.00003490534,0.00000452985],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.09515149,"threshold_uncertainty_score":0.6336961,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4386945140","doi":"10.1007/s13300-023-01468-4","title":"Insulin Therapy for the Management of Diabetes Mellitus: A Narrative Review of Innovative Treatment Strategies","year":2023,"lang":"en","type":"review","venue":"Diabetes Therapy","topic":"Diabetes Management and Research","field":"Medicine","cited_by":28,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"McMaster University","funders":"","keywords":"Medicine; Insulin; Diabetes mellitus; Intensive care medicine; Type 2 diabetes; Type 2 Diabetes Mellitus; Dosing; Internal medicine; Endocrinology","retraction":null,"screen_n_in":null,"score":{"opus":0.1117439629578595,"gpt":0.4155746466091975,"spread":0.303830683651338,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.001508992,0.0008102113,0.003751825,0.0004766311,0.0001246886,0.00004645426,0.0006862232,0.0002108991,0.0001435763],"category_scores_gemma":[0.0000431904,0.0004121384,0.001259147,0.002501029,0.0004301806,0.0001042413,0.0001174503,0.0002814466,0.00002072988],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001354781,"about_ca_system_score_gemma":0.0003807112,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000003022917,"about_ca_topic_score_gemma":5.808183e-7,"domain_scores_codex":[0.9961514,0.0003078599,0.001483864,0.000639167,0.0007011574,0.0007164948],"domain_scores_gemma":[0.9957882,0.001293001,0.001057521,0.001113112,0.0006668287,0.00008139773],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00004228569,0.0004774255,0.0000186648,0.1820345,0.01382827,0.000001664518,0.000343398,4.268614e-7,0.000005040752,0.0007681606,0.00097791,0.8015022],"study_design_scores_gemma":[0.00226267,0.002786661,0.0000841067,0.1471636,0.00117481,5.342326e-8,0.0006451995,0.00001031371,0.0001578246,0.0003770474,0.8449801,0.0003575587],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0003993766,0.9841482,0.000006618869,0.0003534296,0.0002019509,0.01374383,0.0002083366,0.00007537559,0.0008628519],"genre_scores_gemma":[0.00003675791,0.9913365,0.0002151971,0.0002291563,0.0001541433,0.005814574,0.0006242269,0.0001536224,0.001435769],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.8440022,"threshold_uncertainty_score":0.999833,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3083494942","doi":"10.1007/s13300-020-00913-y","title":"Insulin Injection Practices in a Population of Canadians with Diabetes: An Observational Study","year":2020,"lang":"en","type":"article","venue":"Diabetes Therapy","topic":"Diabetes Management and Research","field":"Medicine","cited_by":27,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"Communications Research Centre Canada; Manitoba Beekeepers' Association; Cégep Saint-Jean-sur-Richelieu","funders":"BD; Dexcom; Novo Nordisk; Sanofi; Janssen Pharmaceuticals; AstraZeneca; Eli Lilly and Company; Amgen","keywords":"Medicine; Insulin; Diabetes mellitus; Insulin pen; Observational study; Population; Injection site; Clinical Practice; Type 2 diabetes; Internal medicine; Surgery; Endocrinology; Physical therapy","retraction":null,"screen_n_in":null,"score":{"opus":0.1601835572730593,"gpt":0.369118346198004,"spread":0.2089347889249447,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004041009,0.0001284836,0.0002837309,0.0002172929,0.00004196021,0.00003069593,0.0001138647,0.00004855511,0.00008583697],"category_scores_gemma":[0.000155786,0.0001011487,0.00003077266,0.0007963931,0.00003627609,0.0003723524,0.00001650384,0.0001756396,0.000004199303],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00005044374,"about_ca_system_score_gemma":0.00008743007,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0008335342,"about_ca_topic_score_gemma":0.001482816,"domain_scores_codex":[0.9986453,0.0001413159,0.0002653947,0.0002784668,0.0004063768,0.0002631365],"domain_scores_gemma":[0.9992546,0.00008517633,0.0002073693,0.000193578,0.0001211837,0.0001380515],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0002279378,0.0007673154,0.9781127,0.00007302027,0.0001338733,0.000003645297,0.001430038,0.0001496357,0.001534625,0.0000298337,0.00004172104,0.01749564],"study_design_scores_gemma":[0.002625404,0.004939854,0.9863879,0.00004633269,0.00002682046,2.931937e-8,0.0006811625,0.004566807,0.0002751955,0.00005226881,0.0002865632,0.0001116579],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9966323,0.0001613795,0.000001714701,0.001767022,0.00003017726,0.001088466,0.000006184389,0.00003829813,0.0002744634],"genre_scores_gemma":[0.9983379,0.0000127948,0.0001664769,0.001083833,0.0001051048,0.0000804788,0.0001348122,0.00002526106,0.00005331484],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.01738398,"threshold_uncertainty_score":0.4124726,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2788976924","doi":"10.1007/s13300-018-0375-7","title":"Insulin Matters: A Practical Approach to Basal Insulin Management in Type 2 Diabetes","year":2018,"lang":"en","type":"article","venue":"Diabetes Therapy","topic":"Diabetes Management and Research","field":"Medicine","cited_by":26,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"McGill University; Dalhousie University; Centre for Family Medicine; Horizon Health Network; Island Health; Lakeshore General Hospital; University of Toronto; Western University; St. Michael's Hospital; Trillium Health Centre; Saint John Regional Hospital; LMC Diabetes & Endocrinology (Canada); Alberta Health Services; Nova Scotia Health Authority; Credit Valley Hospital; Health Sciences Centre; McMaster University; Winnipeg Regional Health Authority","funders":"Sanofi","keywords":"Medicine; Type 2 diabetes; Prediabetes; Glycemic; Diabetes mellitus; Intensive care medicine; Insulin resistance; Diabetes management; Nephropathy; Endocrinology","retraction":null,"screen_n_in":null,"score":{"opus":0.04182465527090936,"gpt":0.3330721675094244,"spread":0.2912475122385151,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0008799138,0.00030613,0.0004717882,0.0006573054,0.00008212902,0.0001132535,0.0003046135,0.000128114,0.0004560806],"category_scores_gemma":[0.00009325517,0.0002498224,0.00009667696,0.001344471,0.0001929543,0.0001873466,0.0002297946,0.0003323928,0.001247572],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001007734,"about_ca_system_score_gemma":0.00004505487,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00000485191,"about_ca_topic_score_gemma":0.000002240785,"domain_scores_codex":[0.9972295,0.0001457609,0.0003889913,0.0006312353,0.0006054405,0.0009990428],"domain_scores_gemma":[0.9987473,0.0001104632,0.00006082916,0.0006371592,0.0001518761,0.0002923695],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"observational","study_design_scores_codex":[0.001822524,0.006683173,0.1768571,0.0007673526,0.001626791,0.00007318339,0.00159034,0.00001764832,0.01015627,0.002298261,0.1312244,0.666883],"study_design_scores_gemma":[0.01284003,0.005826297,0.4875244,0.0005395103,0.0001417989,7.447281e-7,0.0005700174,0.006723744,0.01283809,0.002118927,0.4695751,0.001301297],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9593537,0.0007099148,0.00005416964,0.009116222,0.0003208314,0.00173683,0.000003919679,0.0001305793,0.02857377],"genre_scores_gemma":[0.9585537,0.0003896604,0.01242917,0.02493471,0.0006486493,0.0003381031,0.00007802311,0.0001089811,0.002519028],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.6655817,"threshold_uncertainty_score":0.9999954,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2060423751","doi":"10.1007/s13300-012-0007-6","title":"Cost of Self-Monitoring of Blood Glucose in Canada among Patients on an Insulin Regimen for Diabetes","year":2012,"lang":"en","type":"article","venue":"Diabetes Therapy","topic":"Diabetes Management and Education","field":"Medicine","cited_by":26,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"","funders":"Novo Nordisk","keywords":"Medicine; Diabetes mellitus; Insulin; Regimen; Pharmacy; Type 2 diabetes; Medical prescription; Diabetes management; Internal medicine; Intensive care medicine; Emergency medicine; Endocrinology; Pharmacology; Family medicine","retraction":null,"screen_n_in":null,"score":{"opus":0.01831702343357181,"gpt":0.2594698090616091,"spread":0.2411527856280373,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003084121,0.0001528698,0.0003429577,0.0001596159,0.00002385959,0.000006107467,0.000118273,0.00004962675,0.00001605796],"category_scores_gemma":[0.00005709928,0.0001398929,0.00005177969,0.000215196,0.00002530221,0.0001979127,0.00001372479,0.00007563345,8.441544e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001325109,"about_ca_system_score_gemma":0.0001157979,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.006995402,"about_ca_topic_score_gemma":0.001856423,"domain_scores_codex":[0.9987916,0.00004358538,0.0003342564,0.0001624441,0.0002396101,0.0004284907],"domain_scores_gemma":[0.9991257,0.0001384882,0.0002051604,0.0002915869,0.0001132342,0.0001258046],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.00004588694,0.001499757,0.9694104,0.0001483738,0.000153893,5.431468e-8,0.0006471387,0.000004977189,0.002395431,0.00001431101,0.0001112535,0.02556853],"study_design_scores_gemma":[0.002297341,0.0006014607,0.8146442,0.0001485813,0.00005974199,2.691125e-9,0.000164297,0.00005252514,0.1814823,0.00001507102,0.0004287367,0.000105761],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9977291,0.0006176848,2.339013e-7,0.00004139122,0.0004665362,0.0009363241,0.00001687473,0.00001784477,0.000173999],"genre_scores_gemma":[0.9990174,0.0001032559,0.0002720482,0.0001299477,0.0001720297,0.0001528986,0.00009883485,0.00003165924,0.00002188869],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1790868,"threshold_uncertainty_score":0.9996171,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2320992886","doi":"10.1007/s13300-016-0166-y","title":"Clinical Effectiveness and Safety of Analog Glargine in Type 1 Diabetes: A Systematic Review and Meta-Analysis","year":2016,"lang":"en","type":"review","venue":"Diabetes Therapy","topic":"Diabetes Management and Research","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"","funders":"Conselho Nacional de Desenvolvimento Científico e Tecnológico; Academy of Medical Sciences","keywords":"Medicine; Meta-analysis; Type 2 diabetes; Insulin glargine; Diabetes mellitus; Systematic review; Intensive care medicine; MEDLINE; Pharmacology; Internal medicine; Endocrinology","retraction":null,"screen_n_in":null,"score":{"opus":0.1050461465226832,"gpt":0.4300505902930734,"spread":0.3250044437703902,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","metaepi_broad"],"consensus_categories":[],"category_scores_codex":[0.006933862,0.0005815377,0.01584519,0.000849091,0.00003260291,0.00002708598,0.0002822914,0.0003004701,0.000264355],"category_scores_gemma":[0.0006236507,0.0002926819,0.002191291,0.001789779,0.0002734973,0.00007451901,0.0001566444,0.0003939137,0.00001769229],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00004555347,"about_ca_system_score_gemma":0.00008054235,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000001322714,"about_ca_topic_score_gemma":0.000001267486,"domain_scores_codex":[0.9941044,0.002436726,0.001827793,0.0007340859,0.0004115521,0.0004854023],"domain_scores_gemma":[0.9950895,0.002878203,0.0006965559,0.0009529291,0.0001945352,0.0001883122],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","study_design_scores_codex":[0.00001421869,0.00013034,0.002297195,0.7268881,0.1745058,0.000003790786,0.00000371072,2.072349e-8,3.606074e-7,0.00002261627,0.00002290738,0.09611092],"study_design_scores_gemma":[0.001197631,0.0006404452,0.001764293,0.1880094,0.7740566,3.478373e-7,0.000001581681,0.000007109984,9.981779e-7,0.00004246186,0.03385086,0.0004282329],"study_design_candidate":"meta_analysis","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0003902319,0.9934624,0.000002528169,0.000109993,0.0000378031,0.005809253,0.00006510991,0.0000216167,0.0001010578],"genre_scores_gemma":[0.0002323363,0.9984213,0.00003177409,0.000279222,0.00002932583,0.0005378885,0.00008971053,0.00005972306,0.000318684],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.5995508,"threshold_uncertainty_score":0.9999526,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4401163838","doi":"10.1007/s13300-024-01628-0","title":"Medication-Induced Hyperglycemia and Diabetes Mellitus: A Review of Current Literature and Practical Management Strategies","year":2024,"lang":"en","type":"review","venue":"Diabetes Therapy","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Calgary; University of British Columbia","funders":"AstraZeneca; Amgen","keywords":"Medicine; Diabetes mellitus; Intensive care medicine; Endocrinology","retraction":null,"screen_n_in":null,"score":{"opus":0.04936297382883068,"gpt":0.383220159848608,"spread":0.3338571860197773,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.000535353,0.0007438691,0.002428855,0.0003981144,0.00004832357,0.0001560723,0.0001299319,0.0002318073,0.00005620502],"category_scores_gemma":[0.0000426933,0.0004764664,0.0004148212,0.0005607143,0.0001518843,0.0001904759,0.0001686916,0.0005091112,0.00002644826],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00007085916,"about_ca_system_score_gemma":0.0001557668,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":3.787912e-7,"about_ca_topic_score_gemma":1.473031e-7,"domain_scores_codex":[0.9972578,0.0001642179,0.0008541244,0.0007897686,0.0004868363,0.0004472902],"domain_scores_gemma":[0.9984261,0.0002227466,0.0003736058,0.0006580174,0.00009809715,0.0002213949],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.000004248098,0.0001645226,0.00002134045,0.3156289,0.001930198,0.00001755337,0.00005181231,8.67088e-10,0.000001775264,0.001947747,0.002630408,0.6776015],"study_design_scores_gemma":[0.0004754961,0.00032114,0.00002884169,0.2721157,0.006277476,0.000003859074,0.00001748347,0.000002236472,0.000006412396,0.00042841,0.7200363,0.0002866033],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0005047028,0.9944929,9.558339e-7,0.0005767013,0.0003405176,0.002963271,0.00004960284,0.00009639493,0.0009748826],"genre_scores_gemma":[0.00008653982,0.9972889,0.0003055001,0.0004153713,0.0001760876,0.0008311831,0.0006380226,0.00009077693,0.0001676338],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.7174059,"threshold_uncertainty_score":0.9997687,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3015457795","doi":"10.1007/s13300-020-00802-4","title":"Systemic Delivery of siRNA Specific for Silencing TLR4 Gene Expression Reduces Diabetic Cardiomyopathy in a Mouse Model of Streptozotocin-Induced Type 1 Diabetes","year":2020,"lang":"en","type":"article","venue":"Diabetes Therapy","topic":"Cardiac Fibrosis and Remodeling","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Western University","funders":"National Natural Science Foundation of China","keywords":"Diabetic cardiomyopathy; Streptozotocin; Gene silencing; Medicine; Diabetes mellitus; TLR4; Type 2 diabetes; Gene; Cardiomyopathy; Gene expression; Bioinformatics; Internal medicine; Endocrinology; Genetics; Heart failure; Biology; Receptor","retraction":null,"screen_n_in":null,"score":{"opus":0.04397344159512325,"gpt":0.2541219888776776,"spread":0.2101485472825543,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003629812,0.0002926991,0.001176746,0.0001921815,0.00004305382,0.00001454081,0.0001724472,0.0001820221,0.000007439337],"category_scores_gemma":[0.00006878355,0.0002450371,0.0004397598,0.0003204981,0.00005548933,0.0001044578,0.00005281607,0.0001784979,0.000001449755],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00007029212,"about_ca_system_score_gemma":0.0001267069,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000006047599,"about_ca_topic_score_gemma":1.4999e-7,"domain_scores_codex":[0.9978834,0.00008565209,0.0007654579,0.0004791342,0.0003591334,0.0004271888],"domain_scores_gemma":[0.9986656,0.0001734679,0.0002927939,0.0004055945,0.0003097528,0.0001527571],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.0002788369,0.000100657,0.02004494,0.0005644374,0.0001233956,3.947873e-7,0.001458524,0.006865591,0.9658012,0.000002831568,0.00004375906,0.0047154],"study_design_scores_gemma":[0.002083643,0.0006593755,0.0009625113,0.0008630604,0.00005363255,2.15778e-7,0.000336855,0.04327746,0.9515096,0.00002370798,0.000005363695,0.0002245756],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9882012,0.009996885,0.00007852131,0.00006105257,0.0001511211,0.00134429,0.00009380252,0.00004928521,0.00002383281],"genre_scores_gemma":[0.996281,0.001385196,0.001795162,0.0001073063,0.000217931,0.00008578697,0.00004095398,0.00007788637,0.0000087363],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.03641187,"threshold_uncertainty_score":0.9992324,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3088605312","doi":"10.1007/s13300-020-00925-8","title":"The Safety and Efficacy of Second-Generation Basal Insulin Analogues in Adults with Type 2 Diabetes at Risk of Hypoglycemia and Use in Other Special Populations: A Narrative Review","year":2020,"lang":"en","type":"review","venue":"Diabetes Therapy","topic":"Diabetes Management and Research","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Toronto; St. Michael's Hospital","funders":"Sanofi","keywords":"Medicine; Hypoglycemia; Insulin glargine; Insulin; Diabetes mellitus; Glycated hemoglobin; Type 2 diabetes; Glycemic; Internal medicine; Insulin degludec; Type 2 Diabetes Mellitus; Population; Type 1 diabetes; Endocrinology; Intensive care medicine","retraction":null,"screen_n_in":null,"score":{"opus":0.04880216298259601,"gpt":0.3233986099411573,"spread":0.2745964469585613,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007366954,0.0003340947,0.00168898,0.0002560642,0.00007061764,0.00002621924,0.000131496,0.0001452845,0.00007660331],"category_scores_gemma":[0.0004497712,0.0001915102,0.0001249523,0.0008395763,0.0002613637,0.0001065297,0.0000806429,0.0003661908,0.000002279181],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00006988789,"about_ca_system_score_gemma":0.0000901036,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00001429375,"about_ca_topic_score_gemma":0.0006431458,"domain_scores_codex":[0.9976071,0.0005891985,0.0008317701,0.000404742,0.0002875712,0.000279606],"domain_scores_gemma":[0.9982601,0.0007268807,0.0005141399,0.0003164372,0.0001072081,0.00007518849],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0005560013,0.0001351848,0.07282639,0.01307363,0.0004998769,0.000002701667,0.0006493298,0.000001169021,0.00001217028,0.00003695963,0.0004732063,0.9117334],"study_design_scores_gemma":[0.008381833,0.002679591,0.160173,0.0952922,0.0007579773,4.506036e-7,0.0001005492,0.0002419702,0.00003669731,0.00007049036,0.731611,0.0006542443],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.240793,0.7569239,9.11167e-8,0.00007944967,0.00004978431,0.002010815,0.00006747138,0.000006127092,0.00006931732],"genre_scores_gemma":[0.002210256,0.99685,0.00008181981,0.0001142393,0.0001941371,0.00007435864,0.000316712,0.00004440555,0.0001141275],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9110791,"threshold_uncertainty_score":0.7809561,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4404338793","doi":"10.1007/s13300-024-01668-6","title":"Oral Semaglutide Use in Type 2 Diabetes: A Pooled Analysis of Clinical and Patient-Reported Outcomes from Seven PIONEER REAL Prospective Real-World Studies","year":2024,"lang":"en","type":"article","venue":"Diabetes Therapy","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"University of British Columbia","funders":"Novo Nordisk","keywords":"Semaglutide; Medicine; Type 2 diabetes; Diabetes mellitus; Pooled analysis; Prospective cohort study; Meta-analysis; Pediatrics; Internal medicine; Endocrinology","retraction":null,"screen_n_in":null,"score":{"opus":0.06154668834699784,"gpt":0.3677193614407986,"spread":0.3061726730938008,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004426996,0.0003245485,0.001603427,0.0007648641,0.00003228076,0.00005030179,0.00007258848,0.00009281889,0.00007347904],"category_scores_gemma":[0.0002126923,0.0002302417,0.0003525048,0.001564595,0.0001875066,0.0001601894,0.00008443774,0.0001820067,0.000006589209],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00009203711,"about_ca_system_score_gemma":0.0000535048,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0004995264,"about_ca_topic_score_gemma":0.0008389862,"domain_scores_codex":[0.9975559,0.0001546913,0.0009569924,0.0006286269,0.0003315363,0.0003723248],"domain_scores_gemma":[0.9981918,0.0008601185,0.0001959926,0.0004617585,0.0001736406,0.000116681],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0001718946,0.0004991817,0.9260836,0.00005009734,0.03444549,0.00004578774,0.001226625,0.000009873729,0.000331003,0.00008894696,0.0004494737,0.03659805],"study_design_scores_gemma":[0.002344602,0.0007012006,0.9886166,0.0002268087,0.004933406,2.637186e-8,0.0002454256,0.0009134907,0.0007373542,0.0004313173,0.0006351676,0.0002145819],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9926401,0.005318803,5.419946e-7,0.0003590531,0.0003310864,0.0008659833,0.00005429155,0.0001373673,0.0002927188],"genre_scores_gemma":[0.9945446,0.003599137,0.0004089855,0.0004362012,0.00004109463,0.0001088033,0.0001575812,0.00004252118,0.0006610441],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.06253304,"threshold_uncertainty_score":0.9388985,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2299595115","doi":"10.1007/s13300-016-0163-1","title":"Simultaneous Reduction in Both HbA1c and Body Weight with Canagliflozin Versus Glimepiride in Patients with Type 2 Diabetes on Metformin","year":2016,"lang":"en","type":"article","venue":"Diabetes Therapy","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"St. Michael's Hospital; University of Toronto","funders":"Janssen Research and Development","keywords":"Canagliflozin; Glimepiride; Medicine; Metformin; Glycemic; Hypoglycemia; Type 2 diabetes; Diabetes mellitus; Adverse effect; Internal medicine; Urology; Weight loss; Endocrinology; Gastroenterology; Obesity","retraction":null,"screen_n_in":null,"score":{"opus":0.006691807101830577,"gpt":0.2175783256292734,"spread":0.2108865185274429,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001364444,0.0002972622,0.0004184084,0.0003204492,0.00003669744,0.00002139066,0.0000742106,0.00007080156,0.00005240702],"category_scores_gemma":[0.00003389231,0.0001638991,0.00002723122,0.0003652309,0.00009782721,0.0001680668,0.00001871724,0.00009895336,0.00001469763],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002201741,"about_ca_system_score_gemma":0.00003825585,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00004614431,"about_ca_topic_score_gemma":0.0001190496,"domain_scores_codex":[0.9985205,0.00004640513,0.0002142944,0.0004255713,0.0002864373,0.0005068241],"domain_scores_gemma":[0.9992291,0.0001949535,0.00008392183,0.0003153904,0.00005959057,0.0001170312],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.00411349,0.0008010287,0.8742461,0.00003215421,0.0004247641,0.00002680207,0.0001326922,0.00001281889,0.001565605,0.00006463026,0.0001442462,0.1184356],"study_design_scores_gemma":[0.0518069,0.02176671,0.8974757,0.001000312,0.0002115344,3.383578e-7,0.00007479596,0.0001500582,0.01872161,0.0001103919,0.007985676,0.00069601],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9973843,0.0005805108,6.382298e-7,0.0003386771,0.000148622,0.0009389088,0.000007660477,0.00005330695,0.0005473394],"genre_scores_gemma":[0.998644,0.0003984175,0.0001946204,0.000206639,0.00005217475,0.0000838575,0.00004511012,0.00005070601,0.0003244565],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1177396,"threshold_uncertainty_score":0.6683613,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4393114796","doi":"10.1007/s13300-024-01549-y","title":"Validity of Montreal Cognitive Assessment to Detect Cognitive Impairment in Individuals with Type 2 Diabetes","year":2024,"lang":"en","type":"article","venue":"Diabetes Therapy","topic":"Dementia and Cognitive Impairment Research","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"","funders":"Indian Council of Medical Research","keywords":"Montreal Cognitive Assessment; Medicine; Cognitive impairment; Type 2 diabetes; Diabetes mellitus; Cognition; Gerontology; Psychiatry; Endocrinology","retraction":null,"screen_n_in":null,"score":{"opus":0.02273430786966418,"gpt":0.3412973756145462,"spread":0.318563067744882,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009183652,0.0003068056,0.0005501065,0.0005488733,0.00004796937,0.00007517404,0.000110912,0.00008777116,0.0005242494],"category_scores_gemma":[0.00008945516,0.0002252247,0.0001214289,0.001041826,0.0001440956,0.0001435424,0.00006886141,0.0003284387,0.00005615099],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001160546,"about_ca_system_score_gemma":0.0003333948,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00003333151,"about_ca_topic_score_gemma":0.00002463255,"domain_scores_codex":[0.9974232,0.0002583415,0.0003602293,0.000531325,0.0007522587,0.0006746952],"domain_scores_gemma":[0.9984109,0.0007261142,0.00006089318,0.0001681406,0.0003958375,0.0002381265],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0003161535,0.0006185034,0.8880688,0.0001820157,0.0006984695,0.00003655542,0.0006775294,8.3959e-7,0.006152563,0.000006788062,0.0001453676,0.1030964],"study_design_scores_gemma":[0.003586551,0.01016749,0.8831058,0.00162492,0.0001595734,0.000001354423,0.0004671762,0.00009859666,0.1001615,0.0002137812,0.0001770286,0.000236254],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9937779,0.001177798,0.00007839171,0.0002812325,0.00009335611,0.002245934,0.0001376257,0.00008169868,0.002126041],"genre_scores_gemma":[0.9979097,0.000327249,0.0002498053,0.000604004,0.00007642239,0.0004758772,0.0001392612,0.00005287012,0.0001648248],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1028602,"threshold_uncertainty_score":0.9184396,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3087074883","doi":"10.1007/s13300-020-00915-w","title":"Understanding the Clinical Profile of Insulin Degludec, the Latest Basal Insulin Approved for Use in Canada: a Narrative Review","year":2020,"lang":"en","type":"review","venue":"Diabetes Therapy","topic":"Diabetes Management and Research","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"Saint John Regional Hospital; University of Manitoba","funders":"Novo Nordisk","keywords":"Insulin degludec; Medicine; Insulin glargine; Insulin; Basal insulin; Pharmacodynamics; Dosing; Hypoglycemia; Basal (medicine); Pharmacology; Intensive care medicine; Pharmacokinetics; Diabetes mellitus; Endocrinology; Type 2 diabetes","retraction":null,"screen_n_in":null,"score":{"opus":0.3210177804826985,"gpt":0.4114274718680376,"spread":0.09040969138533911,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00250981,0.0004904583,0.002833346,0.0001219914,0.000125306,0.00004978881,0.0007430532,0.0001948788,0.00007989864],"category_scores_gemma":[0.001267232,0.0002323208,0.0007204061,0.001086125,0.0002831018,0.0000759108,0.0001621839,0.001089152,0.000007303463],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005258111,"about_ca_system_score_gemma":0.003093652,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002686318,"about_ca_topic_score_gemma":0.01826754,"domain_scores_codex":[0.9957784,0.0009880483,0.001487459,0.0005661209,0.0005783623,0.0006016253],"domain_scores_gemma":[0.9940526,0.004208766,0.0006850184,0.0007463649,0.0001602069,0.0001470003],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0001144788,0.0002077497,0.001113462,0.03219902,0.001363204,0.000009835755,0.0002089286,6.886987e-7,5.536389e-7,0.0001263546,0.03898496,0.9256707],"study_design_scores_gemma":[0.001664922,0.0004653842,0.0002811541,0.0298955,0.0005167158,2.51713e-7,0.000227501,0.0003314678,0.0000019132,0.0001086988,0.9662246,0.0002818874],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0001707257,0.9848506,0.00001805289,0.003996001,0.0002246299,0.01035511,0.0001317964,0.0000192974,0.0002337509],"genre_scores_gemma":[0.0002733059,0.9948305,0.0001280164,0.00267739,0.0002285701,0.001291004,0.0002732321,0.00009029177,0.0002076878],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9272397,"threshold_uncertainty_score":0.9996465,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4387033802","doi":"10.1007/s13300-023-01464-8","title":"Humanistic and Economic Burden of Patients with Cardiorenal Metabolic Conditions: A Systematic Review","year":2023,"lang":"en","type":"review","venue":"Diabetes Therapy","topic":"Chronic Kidney Disease and Diabetes","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"","funders":"Eli Lilly and Company; Boehringer Ingelheim","keywords":"Medicine; Population; MEDLINE; Health care; Ethnic group; Disease burden; Intensive care medicine; Gerontology; Environmental health","retraction":null,"screen_n_in":null,"score":{"opus":0.02478824564043568,"gpt":0.3097358291103745,"spread":0.2849475834699388,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0002589644,0.0004641855,0.00503411,0.0002186444,0.00005000843,0.00002312978,0.0001534313,0.0001194371,0.0001365688],"category_scores_gemma":[0.0001208623,0.0002922781,0.0005748334,0.0002004785,0.0001405337,0.00005152287,0.00003650751,0.0001557743,0.0001092919],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00008141006,"about_ca_system_score_gemma":0.0004826549,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000006762033,"about_ca_topic_score_gemma":4.766235e-7,"domain_scores_codex":[0.9979668,0.0001762338,0.0009148956,0.0003951059,0.0002466627,0.0003002756],"domain_scores_gemma":[0.9980963,0.0003458069,0.0006087372,0.0006464331,0.00009526311,0.0002074813],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","study_design_scores_codex":[0.0000041709,0.00005215198,0.0002225478,0.9871169,0.00355612,0.000002722816,0.00001691611,7.934048e-8,9.682822e-8,0.00008042769,0.0004995978,0.008448294],"study_design_scores_gemma":[0.001432818,0.000282946,0.0003029707,0.9097669,0.02091878,0.000001852755,0.000006165722,0.000002848815,0.000001043562,0.00004024684,0.06684756,0.0003958856],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.001426905,0.9928614,1.082651e-7,0.00001236774,0.00006293878,0.0044795,0.001035525,0.00006250406,0.00005872011],"genre_scores_gemma":[0.0001830702,0.9965355,0.000006653641,0.0001599419,0.0001215483,0.001085426,0.001722882,0.000106081,0.00007886605],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.07734999,"threshold_uncertainty_score":0.9999529,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4390945704","doi":"10.1007/s13300-023-01527-w","title":"Emotional, Psychological, and Social Well-being Experience of Long-Term Living with Type 1 Diabetes Mellitus: A Patient–Psychiatrist–Endocrinologist Perspective","year":2024,"lang":"en","type":"article","venue":"Diabetes Therapy","topic":"Diabetes Management and Research","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Canadian Mental Health Association; Trillium Health Centre; University of Toronto","funders":"","keywords":"Quality of life (healthcare); Medicine; Denial; Mental health; Anxiety; Distress; Perspective (graphical); Type 1 diabetes; Stressor; Psychiatry; Depression (economics); Anger; Clinical psychology; Psychology; Diabetes mellitus; Psychotherapist; Nursing","retraction":null,"screen_n_in":null,"score":{"opus":0.02289017211454716,"gpt":0.329286928443934,"spread":0.3063967563293868,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001649823,0.0002359957,0.0003724965,0.0002445696,0.0001605136,0.0001150892,0.0001515924,0.00008383597,0.000362006],"category_scores_gemma":[0.00003631046,0.0001614306,0.0001079569,0.0004888548,0.0005869902,0.0001553705,0.00007947199,0.0002767321,0.00002070543],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00005103584,"about_ca_system_score_gemma":0.00002945112,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000003111263,"about_ca_topic_score_gemma":0.000001062881,"domain_scores_codex":[0.9982175,0.0000894493,0.0002439817,0.0005299115,0.0003918769,0.0005272326],"domain_scores_gemma":[0.9992349,0.000206735,0.00006984017,0.0002241497,0.0001828011,0.00008160883],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0001323252,0.0007760791,0.8986908,0.0005138467,0.0007099851,0.00003406597,0.006874382,0.000001230334,0.004601132,0.002194832,0.0007551821,0.08471619],"study_design_scores_gemma":[0.001525121,0.005780012,0.9790809,0.00123804,0.0001329871,0.000003171778,0.003822036,0.0002380782,0.004845601,0.001158535,0.001629953,0.0005455544],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9768345,0.0186613,0.00001174331,0.0008228041,0.0002194144,0.0004689685,0.000004072858,0.0001324517,0.00284479],"genre_scores_gemma":[0.9969967,0.001845614,0.0001988768,0.0003640669,0.0001726253,0.00005390132,0.00001524404,0.00003646807,0.0003165131],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.08417064,"threshold_uncertainty_score":0.6582947,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2982524000","doi":"10.1007/s13300-019-00716-w","title":"The Association Between Phosphorylated Neurofilament Heavy Chain (pNF-H) and Small Fiber Neuropathy (SFN) in Patients with Impaired Glucose Tolerance","year":2019,"lang":"en","type":"article","venue":"Diabetes Therapy","topic":"Pain Mechanisms and Treatments","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"","funders":"Tianjin Medical University; Natural Science Foundation of Tianjin City","keywords":"Medicine; Impaired glucose tolerance; Diabetes mellitus; Diabetic neuropathy; Internal medicine; Phosphorylation; Neurofilament; Endocrinology; Type 2 diabetes; Biochemistry; Immunohistochemistry; Biology","retraction":null,"screen_n_in":null,"score":{"opus":0.005446343467524524,"gpt":0.1910564402811468,"spread":0.1856100968136223,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003154005,0.0002016454,0.0003114213,0.00004650384,0.00008331357,0.00004014319,0.00007247415,0.00007473883,0.00001985924],"category_scores_gemma":[0.00002289194,0.0001252106,0.00004484403,0.0001739386,0.00001889591,0.00005731831,0.00001960444,0.0001602278,0.00002972917],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001145932,"about_ca_system_score_gemma":0.00002375801,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0000199859,"about_ca_topic_score_gemma":0.000004135059,"domain_scores_codex":[0.998717,0.000138154,0.0002114843,0.000295239,0.0002607642,0.0003773482],"domain_scores_gemma":[0.9992468,0.0001910443,0.0001380272,0.0002700181,0.00006860015,0.00008546854],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0003486592,0.0002022988,0.9619556,0.000009322451,0.0001207125,0.000002703338,0.0001795689,0.000003462926,0.0007195185,0.00000607323,0.00001108555,0.03644098],"study_design_scores_gemma":[0.007204718,0.001787916,0.9827189,0.00006463689,0.00002826085,9.224739e-8,0.00001037065,0.0001634726,0.007072773,0.0000448106,0.0007754655,0.0001286198],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9975657,0.000751318,0.000001019483,0.0003200969,0.00009363334,0.001148932,0.00001235793,0.00004116985,0.00006571824],"genre_scores_gemma":[0.9985108,0.0002498731,0.00005736078,0.0006353165,0.00002946881,0.0000478338,0.00005309983,0.00003719144,0.0003790891],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.03631236,"threshold_uncertainty_score":0.5105938,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2973028609","doi":"10.1007/s13300-019-00687-y","title":"Family Members: The Forgotten Players in the Diabetes Care Team (The TALK-HYPO Study)","year":2019,"lang":"en","type":"article","venue":"Diabetes Therapy","topic":"Diabetes Management and Education","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Western University","funders":"Novo Nordisk","keywords":"Hypoglycemia; Medicine; Diabetes mellitus; Type 1 diabetes; Family medicine; Type 2 diabetes; Health care; Pediatrics; Nursing; Endocrinology","retraction":null,"screen_n_in":null,"score":{"opus":0.01495811187501777,"gpt":0.2623535770906601,"spread":0.2473954652156423,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001059822,0.0002870332,0.0003426916,0.0001293422,0.0002000187,0.0001560837,0.0007234659,0.00007076148,0.0001630789],"category_scores_gemma":[0.0000500856,0.0001326744,0.0001691683,0.0006161112,0.0001140917,0.0001782662,0.00006461582,0.0003587983,0.0003134014],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00007737358,"about_ca_system_score_gemma":0.0000478532,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00005614437,"about_ca_topic_score_gemma":0.00003121361,"domain_scores_codex":[0.997945,0.000248921,0.0003130944,0.0003628024,0.0005314265,0.0005988032],"domain_scores_gemma":[0.9981838,0.0004846154,0.0001224772,0.001075941,0.00008249286,0.00005060764],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.00002956184,0.0003939742,0.9312168,0.00004511067,0.0002504112,8.80187e-7,0.01782277,0.00002283316,0.001089999,0.00006124253,0.009679449,0.03938698],"study_design_scores_gemma":[0.00226293,0.0008927367,0.8261446,0.00006606237,0.0001254511,1.367139e-7,0.07914561,0.0002427035,0.0005931311,0.0001564732,0.09013497,0.0002352428],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9809435,0.002463664,1.680643e-7,0.003404029,0.0006088387,0.003303193,0.000004846125,0.00006174602,0.009210014],"genre_scores_gemma":[0.9888964,0.000115235,0.00001118127,0.009349181,0.000306061,0.0005052739,0.00005297964,0.00003995232,0.0007237092],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1050722,"threshold_uncertainty_score":0.5410305,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3019736633","doi":"10.1007/s13300-020-00812-2","title":"Latest Evidence on Sulfonylureas: What’s New?","year":2020,"lang":"en","type":"review","venue":"Diabetes Therapy","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Toronto; St. Michael's Hospital","funders":"Servier","keywords":"Medicine; Diabetes mellitus; Type 2 Diabetes Mellitus; Type 2 diabetes; Clinical trial; Intensive care medicine; Internal medicine; Endocrinology","retraction":null,"screen_n_in":null,"score":{"opus":0.1172102963024617,"gpt":0.3570428983825916,"spread":0.2398326020801299,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0001802973,0.000832376,0.002526263,0.0002538663,0.00006081256,0.0002476013,0.000392333,0.0002826545,0.0004833571],"category_scores_gemma":[0.0000911734,0.0005781882,0.0009393376,0.0005329499,0.0000555728,0.00030202,0.00008096328,0.0004342422,0.002248599],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002127684,"about_ca_system_score_gemma":0.0003079275,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000004467339,"about_ca_topic_score_gemma":6.304737e-7,"domain_scores_codex":[0.9974489,0.0001181163,0.0005467724,0.0008294772,0.000461117,0.0005956704],"domain_scores_gemma":[0.9978832,0.0004440859,0.0002837476,0.0009127731,0.00004634477,0.0004298266],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0000246349,0.000203878,0.00007462954,0.003527353,0.001417733,0.00005701405,0.00004799852,6.23175e-8,0.000001736738,0.0001059947,0.02247288,0.9720661],"study_design_scores_gemma":[0.000828851,0.001458609,0.00004107516,0.04727318,0.001400363,0.000001217965,0.000007541276,0.000001573213,0.00002795198,0.00004880602,0.9484665,0.0004442935],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0000626013,0.9930665,8.735568e-7,0.002267982,0.0006903049,0.002437838,0.00001010046,0.000277756,0.001185976],"genre_scores_gemma":[0.00001869133,0.990203,0.0001104757,0.003196993,0.0009453527,0.0003059748,0.0002886129,0.0001681765,0.004762766],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9716218,"threshold_uncertainty_score":0.9996669,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4405458940","doi":"10.1007/s13300-024-01677-5","title":"Cost-Effectiveness of FreeStyle Libre for Glucose Self-Management Among People with Diabetes Mellitus: A Canadian Private Payer Perspective","year":2024,"lang":"en","type":"article","venue":"Diabetes Therapy","topic":"Diabetes Management and Research","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"Abbott (Canada); EVERSANA (Canada); Western University","funders":"Abbott Diabetes Care","keywords":"Medicine; Glycated hemoglobin; Diabetes mellitus; Type 1 diabetes; Type 2 Diabetes Mellitus; Hypoglycemia; Insulin; Blood Glucose Self-Monitoring; Diabetic ketoacidosis; Intensive care medicine; Type 2 diabetes; Internal medicine; Endocrinology; Continuous glucose monitoring","retraction":null,"screen_n_in":null,"score":{"opus":0.01529652371252201,"gpt":0.2837625686593387,"spread":0.2684660449468168,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0008817232,0.0003668243,0.0006165321,0.0006466605,0.0001345896,0.0001556722,0.0002982384,0.0001185051,0.0001090788],"category_scores_gemma":[0.00003084708,0.0002660113,0.0002401298,0.0009697665,0.0001672285,0.0002774785,0.0000681594,0.0002346019,0.00002492828],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003694782,"about_ca_system_score_gemma":0.000193507,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0005803423,"about_ca_topic_score_gemma":0.001096328,"domain_scores_codex":[0.9975067,0.0001378681,0.0002640751,0.0006623103,0.0004529357,0.0009761415],"domain_scores_gemma":[0.9983183,0.0004506899,0.00006241459,0.0005343342,0.0002836304,0.0003506994],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0008429411,0.001377136,0.8396323,0.0101977,0.01150305,0.00008129773,0.003823139,0.0001170937,0.005579516,0.01908495,0.002254841,0.105506],"study_design_scores_gemma":[0.01065871,0.005087425,0.800158,0.004067115,0.001005829,4.706665e-7,0.001400812,0.008847218,0.08414729,0.004549791,0.07885262,0.001224686],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9809834,0.00830669,0.00009267071,0.0005930008,0.0001934583,0.005930297,0.00006888106,0.0002496106,0.003581964],"genre_scores_gemma":[0.9954639,0.0006269588,0.0008069764,0.0001713517,0.0001274365,0.001909155,0.0001304829,0.0001299545,0.0006337612],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1042813,"threshold_uncertainty_score":0.9999792,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4387219824","doi":"10.1007/s13300-023-01479-1","title":"Addressing Insulin Injection Technique: A Follow-up Study of Canadian Patients with Diabetes","year":2023,"lang":"en","type":"article","venue":"Diabetes Therapy","topic":"Intramuscular injections and effects","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"Communications Research Centre Canada; Cégep Saint-Jean-sur-Richelieu","funders":"","keywords":"Medicine; Diabetes mellitus; Insulin; Insulin pen; Diabetes management; Intensive care medicine; Type 2 diabetes; Internal medicine; Endocrinology","retraction":null,"screen_n_in":null,"score":{"opus":0.02703781236884756,"gpt":0.2688425599392266,"spread":0.2418047475703791,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002742383,0.0001682671,0.0003082129,0.001108284,0.0001678282,0.0000230023,0.00007172082,0.00009783629,0.00003855967],"category_scores_gemma":[0.00005177099,0.0001278108,0.00006930476,0.00194037,0.00004365269,0.0000812564,0.00001216341,0.0001727432,0.00001333573],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00007931369,"about_ca_system_score_gemma":0.00009863065,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.004490064,"about_ca_topic_score_gemma":0.004658654,"domain_scores_codex":[0.9988168,0.00008435574,0.0002017491,0.0002374698,0.0002679892,0.0003916526],"domain_scores_gemma":[0.9992206,0.00004924439,0.00007548993,0.0003078339,0.0002129091,0.0001338846],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0001099659,0.0005186236,0.9593926,0.00006174971,0.0002992359,0.000004273514,0.001204967,0.0000324135,0.007183772,0.000004624794,0.0005825429,0.03060522],"study_design_scores_gemma":[0.005312861,0.006878518,0.966105,0.000248371,0.00007395497,3.769339e-7,0.0004368571,0.0001639428,0.01961822,0.0000287053,0.0009201874,0.0002129452],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9975705,0.00007616105,0.000003927198,0.0000473702,0.0002231688,0.001634106,0.00001270382,0.0001474953,0.0002846421],"genre_scores_gemma":[0.9992086,0.00001517625,0.00006659464,0.0001398757,0.00006194578,0.0003185627,0.0000780787,0.00004650009,0.00006470957],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.03039227,"threshold_uncertainty_score":0.6787664,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4323920834","doi":"10.1007/s13300-023-01389-2","title":"Correlation Between Time in Range and HbA1c in People with Type 2 Diabetes on Basal Insulin: Post Hoc Analysis of the SWITCH PRO Study","year":2023,"lang":"en","type":"article","venue":"Diabetes Therapy","topic":"Diabetes Management and Research","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"LMC Diabetes & Endocrinology (Canada)","funders":"Novo Nordisk","keywords":"Medicine; Basal (medicine); Post-hoc analysis; Type 2 diabetes; Diabetes mellitus; Basal insulin; Insulin; Post hoc; Internal medicine; Endocrinology","retraction":null,"screen_n_in":null,"score":{"opus":0.01860608728213856,"gpt":0.2811965862677894,"spread":0.2625904989856508,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008504477,0.000157569,0.000525814,0.0009519996,0.00004440074,0.00002422726,0.0001289704,0.00006540708,0.00006153889],"category_scores_gemma":[0.00007609336,0.00009531538,0.00006297619,0.004550169,0.0000669235,0.00007373116,0.00006798637,0.0002198281,0.00002147239],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00003711093,"about_ca_system_score_gemma":0.00003511172,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00002554055,"about_ca_topic_score_gemma":0.0001450525,"domain_scores_codex":[0.9984862,0.0001756093,0.0002642618,0.0002883147,0.0004472535,0.0003383467],"domain_scores_gemma":[0.9990895,0.0003486269,0.00008260752,0.0003381835,0.00009120591,0.00004986189],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0002491173,0.0003726515,0.9824265,0.00003886742,0.0007684821,0.000002397192,0.001247833,0.000163204,0.00056019,0.000002859693,0.00005538132,0.01411248],"study_design_scores_gemma":[0.002992665,0.002297208,0.9865826,0.00009145193,0.000211006,4.517034e-9,0.0002218726,0.007238223,0.0001947676,0.00002492519,0.00003793049,0.0001073306],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9973331,0.0002591528,1.636803e-7,0.0007164947,0.00003318552,0.001390459,0.00001071651,0.00003208837,0.0002246037],"genre_scores_gemma":[0.999107,0.00007854168,0.00000517436,0.0001513525,0.00003032256,0.00006293704,0.00009433958,0.0000255366,0.000444783],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.01400515,"threshold_uncertainty_score":0.3886848,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4390913863","doi":"10.1007/s13300-023-01528-9","title":"Impact of Living with Stigma in Persons with Type 1 Diabetes: A Patient–Physician Perspective","year":2024,"lang":"en","type":"article","venue":"Diabetes Therapy","topic":"Obesity and Health Practices","field":"Health Professions","cited_by":9,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Trillium Health Centre; University of Toronto","funders":"","keywords":"Medicine; Type 1 diabetes; Stigma (botany); Psychosocial; Quality of life (healthcare); Prejudice (legal term); Shame; Distress; Social stigma; Mental health; Psychiatry; Clinical psychology; Psychology; Diabetes mellitus; Social psychology; Human immunodeficiency virus (HIV); Family medicine; Nursing","retraction":null,"screen_n_in":null,"score":{"opus":0.03303958857861965,"gpt":0.4033121167255165,"spread":0.3702725281468969,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004441701,0.0002284781,0.0004111636,0.0002541565,0.0003076342,0.00002431078,0.0001322907,0.0001297047,0.0005794173],"category_scores_gemma":[0.0001210448,0.0001466926,0.00007319632,0.0008421544,0.0001085964,0.0004335047,0.00002860483,0.0008252756,0.0001007383],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003268395,"about_ca_system_score_gemma":0.0008108272,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0007045116,"about_ca_topic_score_gemma":0.0005992334,"domain_scores_codex":[0.9979011,0.0005295945,0.0002882347,0.0003467727,0.0002421917,0.0006920975],"domain_scores_gemma":[0.996835,0.002368192,0.0001907166,0.0002670158,0.0002215244,0.0001175662],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0001615286,0.0003603067,0.9229338,0.0004915495,0.0003500266,0.000005212599,0.06796642,0.00003292466,0.000909157,0.0003703127,0.0007725853,0.005646237],"study_design_scores_gemma":[0.000615593,0.006594848,0.9510506,0.008902585,0.00005132902,2.071909e-7,0.03000368,0.0006369464,0.0001300931,0.0002352618,0.001376228,0.0004026654],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9884086,0.005752874,0.000002738396,0.0004330568,0.0001565689,0.0007879154,0.0000414724,0.000102902,0.004313874],"genre_scores_gemma":[0.9983912,0.0003721864,0.0001394078,0.00065718,0.000138022,0.0001103057,0.00000517113,0.00005513671,0.000131433],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.03796275,"threshold_uncertainty_score":0.6344213,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3000373527","doi":"10.1007/s13300-019-00749-1","title":"Impact of Switching from Twice-Daily Basal Insulin to Once-Daily Insulin Glargine 300 U/mL in People with Type 1 Diabetes on Basal–Bolus Insulin: Phase 4 OPTIMIZE Study","year":2020,"lang":"en","type":"article","venue":"Diabetes Therapy","topic":"Diabetes Management and Research","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Université Laval","funders":"Universitaire Ziekenhuizen Leuven, KU Leuven; Sanofi","keywords":"Insulin glargine; Medicine; Basal insulin; Insulin; Basal (medicine); Diabetes mellitus; Internal medicine; Endocrinology; Type 2 diabetes","retraction":null,"screen_n_in":null,"score":{"opus":0.03087325850078365,"gpt":0.3243906294112558,"spread":0.2935173709104722,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0008605834,0.0007680999,0.001699733,0.0007225531,0.0001190796,0.0001411671,0.0007358135,0.0002003389,0.0007179421],"category_scores_gemma":[0.0004644819,0.0005692096,0.0002812883,0.002789221,0.00009528662,0.0003231595,0.0002515523,0.0009365435,0.0001644496],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002197517,"about_ca_system_score_gemma":0.000323704,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0002865449,"about_ca_topic_score_gemma":0.00005388249,"domain_scores_codex":[0.9950556,0.0003928571,0.0009436002,0.001138452,0.001237973,0.001231559],"domain_scores_gemma":[0.9970775,0.0006060241,0.0002916641,0.000952003,0.0003387637,0.0007340112],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.01425831,0.009691505,0.8324911,0.0001583076,0.002135685,0.0000893853,0.008053785,0.002481921,0.04014301,0.000005137451,0.001584295,0.08890758],"study_design_scores_gemma":[0.05276236,0.05081237,0.8673981,0.0006053277,0.0002035604,8.758349e-8,0.001046063,0.01579919,0.009614495,0.00006862951,0.0006685778,0.00102119],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9917341,0.001842046,0.00002864575,0.002335997,0.0001746365,0.003189421,0.0001115116,0.0001738378,0.000409732],"genre_scores_gemma":[0.9943711,0.0003485728,0.0008338204,0.003343224,0.0004388627,0.000180644,0.0002190203,0.0001914701,0.00007328888],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.08788639,"threshold_uncertainty_score":0.9996759,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4405657525","doi":"10.1007/s13300-024-01674-8","title":"A Bioequivalence Study of Two Formulations of Oral Semaglutide in Healthy Participants","year":2024,"lang":"en","type":"article","venue":"Diabetes Therapy","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Altasciences (Canada)","funders":"Novo Nordisk","keywords":"Bioequivalence; Semaglutide; Medicine; Cmax; Pharmacokinetics; Crossover study; Confidence interval; Dosing; Pharmacology; Oral administration; Internal medicine; Type 2 diabetes; Diabetes mellitus; Endocrinology; Placebo; Alternative medicine","retraction":null,"screen_n_in":null,"score":{"opus":0.07649554360568715,"gpt":0.3842856745036573,"spread":0.3077901308979701,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002652301,0.0001121553,0.0003362632,0.0002516955,0.0000148319,0.000007862775,0.00006390412,0.00002077213,0.00006211315],"category_scores_gemma":[0.00001261377,0.00008633961,0.00006588342,0.0004594737,0.00003888676,0.0000644445,0.00002396237,0.00005670564,0.000007869462],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00003735174,"about_ca_system_score_gemma":0.00003900987,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001264156,"about_ca_topic_score_gemma":0.00009742866,"domain_scores_codex":[0.9989576,0.00004227992,0.0003464599,0.0001874994,0.0001882557,0.0002779174],"domain_scores_gemma":[0.999535,0.00008124232,0.00005252467,0.0002414159,0.00003434407,0.00005552933],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0001413335,0.002712043,0.9304507,0.0002533035,0.0004558913,0.00001024687,0.002318266,0.0000325938,0.004540214,0.001545955,0.00007650992,0.05746295],"study_design_scores_gemma":[0.01267976,0.01232271,0.9484655,0.0006592973,0.000370659,2.240091e-7,0.0006131459,0.004604073,0.01607028,0.002796206,0.001171467,0.0002466758],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9962662,0.002067638,0.00000882587,0.0002579088,0.00009146587,0.0009346229,0.000007521515,0.00004397828,0.0003217772],"genre_scores_gemma":[0.9992122,0.0001448258,0.0002974589,0.0001198457,0.00001454988,0.0001016471,0.000008657091,0.00001617814,0.00008461453],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.05721628,"threshold_uncertainty_score":0.3520827,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4404202498","doi":"10.1007/s13300-024-01659-7","title":"Cardiovascular, Metabolic, and Safety Outcomes with Semaglutide by Baseline Age: Post Hoc Analysis of SUSTAIN 6 and PIONEER 6","year":2024,"lang":"en","type":"article","venue":"Diabetes Therapy","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Ted Rogers Centre for Heart Research; University of Toronto","funders":"Novo Nordisk","keywords":"Semaglutide; Post-hoc analysis; Medicine; Baseline (sea); Diabetes mellitus; Post hoc; Internal medicine; Type 2 diabetes; Endocrinology; Liraglutide","retraction":null,"screen_n_in":null,"score":{"opus":0.005565111311902527,"gpt":0.2304057548844472,"spread":0.2248406435725447,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004641511,0.0002402875,0.0008989897,0.0003863847,0.00004080207,0.00004910026,0.00004708702,0.00004815541,0.0000624647],"category_scores_gemma":[0.00001712219,0.0001520121,0.0003056274,0.0006366213,0.0001123161,0.00007534215,0.00003338865,0.00007502249,0.00000166575],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00002059924,"about_ca_system_score_gemma":0.00001966356,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00005368008,"about_ca_topic_score_gemma":0.00001372283,"domain_scores_codex":[0.9987932,0.00006576441,0.0002272582,0.0003608933,0.0002881978,0.0002646948],"domain_scores_gemma":[0.9992701,0.000147565,0.00003504243,0.0003589116,0.00007730857,0.0001110301],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"observational","study_design_scores_codex":[0.000349369,0.0003608705,0.3835376,0.0004241544,0.1336343,0.00009447752,0.0008100037,0.00005679197,0.002688896,0.0009254469,0.001186394,0.4759317],"study_design_scores_gemma":[0.00777555,0.001599764,0.677185,0.0001748919,0.03573791,0.000001715665,0.0005112452,0.002190077,0.004352595,0.00008416783,0.2697599,0.0006271608],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.8781891,0.1197713,0.0001135199,0.001073726,0.00003045102,0.0004481078,0.00009534258,0.000072075,0.0002063048],"genre_scores_gemma":[0.9861527,0.01059475,0.0005375901,0.0007496267,0.00002593426,0.00004644834,0.0003373176,0.00003988321,0.001515734],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.4753045,"threshold_uncertainty_score":0.6198875,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4405466175","doi":"10.1007/s13300-024-01671-x","title":"Clinical Profile and Treatment Adherence in Patients with Type 2 Diabetes and Chronic Kidney Disease Who Initiate an SGLT2 Inhibitor: A Multi-cohort Study","year":2024,"lang":"en","type":"article","venue":"Diabetes Therapy","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"McMaster University","funders":"Bayer","keywords":"Medicine; Type 2 diabetes; Diabetes mellitus; Kidney disease; Cohort; Disease; Internal medicine; Cohort study; Intensive care medicine; Endocrinology","retraction":null,"screen_n_in":null,"score":{"opus":0.02515344726231022,"gpt":0.3114057257762158,"spread":0.2862522785139056,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002521884,0.0003604808,0.0005614102,0.0001788649,0.00005874715,0.000118632,0.00006520675,0.00006326028,0.00006719825],"category_scores_gemma":[0.00002577172,0.0002388664,0.00005492552,0.0002513469,0.0001370357,0.0002676207,0.0000511364,0.0001340379,0.0000167431],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001348328,"about_ca_system_score_gemma":0.0001443724,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00001440779,"about_ca_topic_score_gemma":0.00002907336,"domain_scores_codex":[0.9981099,0.0001359549,0.0003438428,0.0007448927,0.0002381927,0.0004271919],"domain_scores_gemma":[0.9989645,0.00007843029,0.00005527618,0.0003855996,0.00005711176,0.0004590726],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0002483094,0.003669606,0.8875445,0.0001042659,0.0007306087,0.00002723571,0.0003839229,3.187506e-7,0.00002527703,0.000006817856,0.00008494178,0.1071743],"study_design_scores_gemma":[0.01116286,0.01825954,0.967832,0.0004525859,0.0003541131,3.637504e-8,0.00005248513,0.000703008,0.0001027112,0.00001844507,0.0007992153,0.0002629381],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9912429,0.004708334,3.370094e-7,0.00006077456,0.0001806333,0.003557431,0.00004425826,0.0001283631,0.00007695452],"genre_scores_gemma":[0.9969918,0.001275118,0.0001104335,0.0003028017,0.0001175779,0.0006032629,0.0002693148,0.00006027425,0.0002693742],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1069113,"threshold_uncertainty_score":0.9740689,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4220897970","doi":"10.1007/s13300-022-01231-1","title":"Exploring a Suitable Marker of Glycemic Response to Dulaglutide in Patients with Type 2 Diabetes: A Retrospective Study","year":2022,"lang":"en","type":"article","venue":"Diabetes Therapy","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"McGill University","funders":"Japan Society for the Promotion of Science","keywords":"Dulaglutide; Glycemic; Medicine; Internal medicine; Postprandial; Diabetes mellitus; Type 2 diabetes; Confounding; Endocrinology; Insulin; Liraglutide","retraction":null,"screen_n_in":null,"score":{"opus":0.02561159043254678,"gpt":0.2412554509608322,"spread":0.2156438605282855,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000623896,0.0002323875,0.0005217834,0.0004731332,0.00008390595,0.0000144662,0.000159223,0.00001943482,0.0002335903],"category_scores_gemma":[0.0000708228,0.0001945079,0.00006218701,0.001167811,0.00002808746,0.0001470929,0.0001504916,0.0001720335,0.00001088217],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004034803,"about_ca_system_score_gemma":0.00004942231,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00001945903,"about_ca_topic_score_gemma":0.000006815131,"domain_scores_codex":[0.9980226,0.0002164831,0.0002917073,0.0004181756,0.0005539961,0.0004970986],"domain_scores_gemma":[0.9990847,0.0000940308,0.00009672339,0.0005075163,0.0001162394,0.0001008569],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0169985,0.00301961,0.9722612,0.00001776425,0.0004906946,0.000009616258,0.00207593,0.00004683129,0.001238294,0.000005554056,0.00009155108,0.003744471],"study_design_scores_gemma":[0.01090986,0.02680614,0.9592585,0.00006513546,0.00006606262,2.684733e-8,0.0009163893,0.00001320872,0.0007170995,0.00001530908,0.00104006,0.0001922393],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9968336,0.0001954182,2.557276e-7,0.0001045582,0.000142873,0.002420356,0.00001824666,0.00005503762,0.0002296646],"genre_scores_gemma":[0.9981025,0.00001434377,0.00009285028,0.0003476602,0.00001539156,0.00100462,0.00003109447,0.00005564532,0.0003358434],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.02378653,"threshold_uncertainty_score":0.79318,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4378783299","doi":"10.1007/s13300-023-01413-5","title":"Greater Combined Reductions of HbA1c ≥ 1.0% and Body Weight Loss ≥ 5.0% or ≥ 10.0% with Orally Administered Semaglutide Versus Comparators","year":2023,"lang":"en","type":"article","venue":"Diabetes Therapy","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Manitoba","funders":"Novo Nordisk; Steno Diabetes Center Copenhagen","keywords":"Semaglutide; Liraglutide; Medicine; Empagliflozin; Sitagliptin; Weight loss; Placebo; Type 2 diabetes; Internal medicine; Diabetes mellitus; Endocrinology; Obesity","retraction":null,"screen_n_in":null,"score":{"opus":0.03918269970728713,"gpt":0.2883983596449021,"spread":0.2492156599376149,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001184589,0.0002653718,0.0005145235,0.0002383684,0.0000937709,0.00002853049,0.00009657995,0.00005928735,0.0005538246],"category_scores_gemma":[0.00001226677,0.0001712763,0.00007919719,0.0005757036,0.0002221505,0.00008006077,0.00004466047,0.00007322615,0.00009581841],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00003431772,"about_ca_system_score_gemma":0.00005403663,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000004161016,"about_ca_topic_score_gemma":0.000004788951,"domain_scores_codex":[0.9987123,0.00004242891,0.0002660661,0.0003358976,0.0002485587,0.0003947489],"domain_scores_gemma":[0.9991319,0.00009648254,0.0001069665,0.0004121803,0.00009465007,0.0001578062],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.02166258,0.002186653,0.8716161,0.0006680378,0.009775419,0.0002711625,0.001625487,0.00001233532,0.01395088,0.001480977,0.05745846,0.01929186],"study_design_scores_gemma":[0.06668334,0.02950344,0.7046645,0.0005741174,0.001550298,0.000007048779,0.0007264249,0.0006216846,0.06262098,0.0002534342,0.1316914,0.00110329],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9956596,0.0001756893,0.000001493955,0.001449505,0.0002053667,0.0006899966,0.00002500742,0.0002035286,0.001589784],"genre_scores_gemma":[0.9888899,0.000239024,0.0003306451,0.0001648031,0.00006524525,0.0001269629,0.0001602428,0.00004927506,0.009973844],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1669516,"threshold_uncertainty_score":0.6984445,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3010968620","doi":"10.1007/s13300-020-00797-y","title":"Fixed-Ratio Combination of Insulin and GLP-1 RA in Patients with Longstanding Type 2 Diabetes: A Subanalysis of LixiLan-L","year":2020,"lang":"en","type":"article","venue":"Diabetes Therapy","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Manitoba Beekeepers' Association","funders":"Sanofi","keywords":"Lixisenatide; Medicine; Insulin glargine; Type 2 diabetes; Internal medicine; Glycated hemoglobin; Endocrinology; Diabetes mellitus; Insulin; Quartile; Gastroenterology; Gastric emptying; Exenatide; Insulin degludec; Confidence interval","retraction":null,"screen_n_in":null,"score":{"opus":0.01154119011127701,"gpt":0.2202640372140185,"spread":0.2087228471027415,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001128365,0.0001483186,0.0004716069,0.0001766421,0.00002033953,0.00001453962,0.00005938426,0.00004545191,0.00003702517],"category_scores_gemma":[0.000038205,0.0001142398,0.00004789841,0.0005637714,0.00007438404,0.0001048527,0.00002277886,0.00005947525,0.000001570434],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00003170929,"about_ca_system_score_gemma":0.00002128988,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000006831692,"about_ca_topic_score_gemma":0.0000037142,"domain_scores_codex":[0.9990565,0.00003740632,0.0002857028,0.0002057245,0.0002369727,0.0001777273],"domain_scores_gemma":[0.9994293,0.00005911523,0.0001639202,0.0001548753,0.0001274232,0.00006533888],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0002752279,0.0005128957,0.9783879,0.0001531274,0.0004323502,7.473353e-7,0.0007872797,0.000008168702,0.002048835,0.00008069118,0.00004247711,0.01727032],"study_design_scores_gemma":[0.008958949,0.003970402,0.9656649,0.0001727852,0.0001891557,6.423949e-9,0.0000907337,0.001007457,0.0195917,0.00005202657,0.0001600246,0.0001419089],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.997883,0.001086026,0.00001104453,0.0002882842,0.00002051022,0.0005230636,0.000009855353,0.0000192147,0.0001590168],"genre_scores_gemma":[0.9990671,0.0002172677,0.0001968811,0.0003100437,0.00001179762,0.00001783939,0.0001426947,0.00001927845,0.00001708337],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.01754286,"threshold_uncertainty_score":0.4658565,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3134228882","doi":"10.1007/s13300-021-01018-w","title":"Efficacy and Safety of Ertugliflozin in Patients With Diabetes Mellitus Inadequately Controlled by Sulfonylurea Monotherapy: a Substudy of VERTIS CV","year":2021,"lang":"en","type":"article","venue":"Diabetes Therapy","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Cambridge Cardiac Care Centre","funders":"Merck Sharp and Dohme; Pfizer","keywords":"Medicine; Internal medicine; Cohort; Sulfonylurea; Placebo; Diabetes mellitus; Adverse effect; Gastroenterology; Insulin; Endocrinology","retraction":null,"screen_n_in":null,"score":{"opus":0.006761234587167101,"gpt":0.2156693836597361,"spread":0.208908149072569,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002410249,0.0003234166,0.001242817,0.0001789204,0.00003267694,0.0000169899,0.0001015554,0.00009059776,0.00009193793],"category_scores_gemma":[0.00004942857,0.0002367263,0.0001183426,0.0004235372,0.0001393254,0.0001011743,0.00003369627,0.00010766,0.000001819752],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00005240832,"about_ca_system_score_gemma":0.00005153543,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00001530652,"about_ca_topic_score_gemma":0.00000857018,"domain_scores_codex":[0.9980759,0.0001348871,0.0005956469,0.0003937311,0.0003756035,0.0004242124],"domain_scores_gemma":[0.9987517,0.0003081931,0.0002289826,0.0004143844,0.0001852548,0.0001114708],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.005049523,0.00336523,0.9026153,0.0001024695,0.001838584,0.000003714632,0.0004797452,0.000004670005,0.009485343,0.00005333115,0.0001089814,0.07689309],"study_design_scores_gemma":[0.09746052,0.00310812,0.8527462,0.0002838018,0.0001890226,3.118145e-8,0.00005880985,0.00005951339,0.04496833,0.00004332518,0.0008516737,0.000230677],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9835022,0.01410344,0.000003875546,0.0002808936,0.0000445781,0.001775061,0.00003696074,0.00002825389,0.0002247166],"genre_scores_gemma":[0.9966908,0.002303594,0.0001556513,0.0003830455,0.00001122876,0.0001205505,0.0001762147,0.00004666773,0.0001122204],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.092411,"threshold_uncertainty_score":0.9653419,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4382182323","doi":"10.1007/s13300-023-01436-y","title":"The Hidden Burden—Exploring Depression Risk in Patients with Diabetic Nephropathy: A Systematic Review and Meta-Analysis","year":2023,"lang":"en","type":"review","venue":"Diabetes Therapy","topic":"Diabetes Management and Education","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"","funders":"","keywords":"Medicine; Diabetic nephropathy; Diabetes mellitus; Observational study; Nephropathy; Meta-analysis; Internal medicine; Odds ratio; Depression (economics); Randomized controlled trial; Type 2 diabetes; Confidence interval; Endocrinology","retraction":null,"screen_n_in":null,"score":{"opus":0.085483647586891,"gpt":0.3165971289875024,"spread":0.2311134814006114,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.001603985,0.0006010022,0.006069367,0.0005582341,0.0001637924,0.0001416937,0.0003239281,0.0001106812,0.00004272698],"category_scores_gemma":[0.0002649507,0.0002802141,0.001111552,0.002040727,0.00006513546,0.0001486021,0.00009016581,0.0003736984,0.00006125263],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00009110237,"about_ca_system_score_gemma":0.0000508322,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00001531598,"about_ca_topic_score_gemma":0.000006626668,"domain_scores_codex":[0.996553,0.0007234943,0.001077014,0.000612553,0.0005330183,0.0005008937],"domain_scores_gemma":[0.9968544,0.0007968399,0.0009414534,0.001167636,0.0001175356,0.0001221551],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","study_design_scores_codex":[0.000006764844,0.0001090353,0.008169104,0.6911502,0.1711096,0.000001723691,0.0001360363,5.79352e-7,9.402257e-9,0.0000047499,0.0001162089,0.1291959],"study_design_scores_gemma":[0.0004487032,0.0001468265,0.002866762,0.06918059,0.914279,7.835435e-8,0.00003015093,0.000008361698,1.393538e-7,0.00002131016,0.01262072,0.000397334],"study_design_candidate":"meta_analysis","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.002785006,0.9903631,6.377776e-7,0.0001008778,0.00006657932,0.006555644,0.0000235668,0.00007740493,0.00002720822],"genre_scores_gemma":[0.000192731,0.9930406,0.00002484907,0.0001837255,0.00004954211,0.005631807,0.0002607713,0.0001129361,0.00050303],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.7431694,"threshold_uncertainty_score":0.999965,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4408921665","doi":"10.1007/s13300-025-01725-8","title":"Systematic Literature Review of the Impact of Type 2 Diabetes and Heart Failure Guideline Adherence on Clinical and Economic Outcomes","year":2025,"lang":"en","type":"review","venue":"Diabetes Therapy","topic":"Medication Adherence and Compliance","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; MEDLINE; Intensive care medicine; Guideline; Disease management; Type 2 diabetes; Systematic review; Diabetes mellitus; Clinical trial; Disease; Internal medicine; Pathology","retraction":null,"screen_n_in":null,"score":{"opus":0.05839507894475807,"gpt":0.4296025219781489,"spread":0.3712074430333908,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009265843,0.0003514597,0.003678877,0.00009224933,0.00002557537,0.00001512268,0.0002594388,0.0002251184,0.0001703691],"category_scores_gemma":[0.0007665366,0.0001656768,0.0006974613,0.0002886498,0.0001800069,0.00003228504,0.00005218577,0.0003599044,0.00002114899],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00002427085,"about_ca_system_score_gemma":0.0004417968,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000001444497,"about_ca_topic_score_gemma":1.902577e-7,"domain_scores_codex":[0.9973149,0.0004262174,0.001590057,0.0003339029,0.0001663279,0.0001686027],"domain_scores_gemma":[0.9970658,0.000922788,0.0008835758,0.0008566663,0.0001743073,0.00009679698],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","study_design_scores_codex":[0.00000574,0.0000798513,0.02318532,0.8538445,0.0009454523,2.609116e-7,0.00001311298,4.098906e-8,0.000002455061,0.00004037965,0.02379311,0.09808974],"study_design_scores_gemma":[0.0003931357,0.000573268,0.002389104,0.9472292,0.0005632203,0.000002166579,0.000003024687,0.000007248168,0.000003839777,0.00003514336,0.0486546,0.0001460264],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.003290528,0.9938928,1.486926e-7,0.0003793401,0.0001653095,0.002117745,0.00007016346,0.00001106762,0.00007291392],"genre_scores_gemma":[0.0001840324,0.997756,0.00007951045,0.001426161,0.00005554716,0.0001081576,0.00005155942,0.00001862642,0.0003204297],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.09794372,"threshold_uncertainty_score":0.6756105,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3038415136","doi":"10.1007/s13300-020-00869-z","title":"Evaluation of Characteristics of Gastrointestinal Adverse Events with Once-Weekly Dulaglutide Treatment in Chinese Patients with Type 2 Diabetes: A Post Hoc Pooled Analysis of Two Randomized Trials","year":2020,"lang":"en","type":"article","venue":"Diabetes Therapy","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Ministry of Education and Child Care","funders":"Eli Lilly and Company","keywords":"Medicine; Dulaglutide; Post-hoc analysis; Type 2 diabetes; Diabetes mellitus; Adverse effect; Internal medicine; Randomized controlled trial; Pooled analysis; Post hoc; Traditional medicine; Exenatide; Meta-analysis; Endocrinology","retraction":null,"screen_n_in":null,"score":{"opus":0.02863615751985996,"gpt":0.3022142693629837,"spread":0.2735781118431238,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001646334,0.0003591661,0.002939935,0.0004685349,0.00001684022,0.000004111507,0.0001084587,0.00003558923,0.0001417134],"category_scores_gemma":[0.0007624989,0.0002080778,0.0004348753,0.00124708,0.0001234043,0.00009420791,0.0000204527,0.00006069974,0.000001737697],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000133855,"about_ca_system_score_gemma":0.0001810468,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00003957009,"about_ca_topic_score_gemma":0.00002740694,"domain_scores_codex":[0.9966291,0.0007480505,0.001083988,0.0003401411,0.0009117085,0.0002869696],"domain_scores_gemma":[0.9967966,0.0005409851,0.001149969,0.0003524943,0.001040828,0.0001190945],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0480146,0.002248778,0.9169344,0.0000900242,0.01298323,0.000002012384,0.0005783347,0.0004009477,0.003199286,0.000004652164,0.000001711154,0.01554205],"study_design_scores_gemma":[0.2292499,0.009710321,0.7359079,0.0003660579,0.01774804,3.514664e-8,0.00005690926,0.00524091,0.001552474,0.00001400281,0.000002260603,0.0001512503],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9960622,0.00032558,0.00001743992,0.0001133617,0.00002786883,0.003241815,0.0001386197,0.0000182836,0.00005482827],"genre_scores_gemma":[0.9977579,0.00009084688,0.000927633,0.0001156796,0.00002388262,0.0001711422,0.0008691244,0.0000318743,0.00001188418],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1812353,"threshold_uncertainty_score":0.8485165,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4214539958","doi":"10.1007/s13300-022-01216-0","title":"Defining Minimum Necessary Communication During Care Transitions for Patients on Antihyperglycemic Medication: Consensus of the Care Transitions Task Force of the IPRO Hypoglycemia Coalition","year":2022,"lang":"en","type":"article","venue":"Diabetes Therapy","topic":"Hyperglycemia and glycemic control in critically ill and hospitalized patients","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Vancouver General Hospital; University of British Columbia","funders":"National Institute on Aging; National Institute of Diabetes and Digestive and Kidney Diseases; Abbott Diabetes Care; Centers for Medicare and Medicaid Services; U.S. Department of Veterans Affairs; Syracuse University; Centers for Disease Control and Prevention","keywords":"Task (project management); Hypoglycemia; Medicine; Task force; Diabetes mellitus; Patient care; Intensive care medicine; Nursing; Public administration; Political science; Management; Endocrinology","retraction":null,"screen_n_in":null,"score":{"opus":0.00876583446230965,"gpt":0.2480795129881739,"spread":0.2393136785258642,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001135423,0.0002029575,0.0003892494,0.00008802417,0.0008746578,0.000008274259,0.000358391,0.0001068852,0.00005005392],"category_scores_gemma":[0.00008043251,0.0001458204,0.0003987901,0.0003119026,0.000315873,0.00004289083,0.00004975228,0.0003248987,5.857168e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001276161,"about_ca_system_score_gemma":0.0001675598,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00001665373,"about_ca_topic_score_gemma":0.000007526518,"domain_scores_codex":[0.9981264,0.0002331658,0.0005694763,0.0002697141,0.0005221076,0.000279121],"domain_scores_gemma":[0.9982061,0.0003147422,0.0001991488,0.0007448915,0.0004671894,0.00006794337],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.02066985,0.005979435,0.4883488,0.004347238,0.001896126,0.000003853607,0.132256,0.001814338,0.3025196,0.01352367,0.002101409,0.02653966],"study_design_scores_gemma":[0.1501375,0.02003096,0.4615251,0.005777755,0.003745043,0.00003901647,0.1129558,0.002572837,0.2230566,0.004430154,0.0131997,0.00252949],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9909047,0.002146061,0.00001339892,0.002683687,0.0003168715,0.001593751,0.001698174,0.00003059241,0.0006127227],"genre_scores_gemma":[0.9974378,0.0001034959,0.0001011557,0.000829916,0.00003284814,0.0005113792,0.000920977,0.0000348744,0.00002758624],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1294677,"threshold_uncertainty_score":0.6727248,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4379260635","doi":"10.1007/s13300-023-01423-3","title":"Real-World Effects of Second-Generation Versus Earlier Intermediate/Basal Insulin Analogues on Rates of Hypoglycemia in Adults with Type 1 and 2 Diabetes (iNPHORM, US)","year":2023,"lang":"en","type":"article","venue":"Diabetes Therapy","topic":"Diabetes Management and Research","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Robarts Clinical Trials; Western University","funders":"Sanofi Pasteur","keywords":"Medicine; Hypoglycemia; Basal (medicine); Diabetes mellitus; Basal insulin; Internal medicine; Insulin; Type 1 diabetes; Endocrinology; Type 2 diabetes","retraction":null,"screen_n_in":null,"score":{"opus":0.02304931753489594,"gpt":0.2940169029136934,"spread":0.2709675853787975,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003509126,0.0002109567,0.0004941818,0.000742647,0.00003044827,0.00001931851,0.0001175587,0.00008642398,0.00006375623],"category_scores_gemma":[0.0001140492,0.0001543565,0.00004968179,0.00116147,0.0002018469,0.0001076746,0.0000528577,0.0001942352,0.00001872487],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00003471028,"about_ca_system_score_gemma":0.00004946016,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00002319252,"about_ca_topic_score_gemma":0.0001949386,"domain_scores_codex":[0.9985385,0.000104268,0.0003089525,0.000314952,0.0003342695,0.0003990779],"domain_scores_gemma":[0.9988648,0.0005019346,0.0001214277,0.0002771862,0.0001440583,0.00009061606],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.002891836,0.0003027697,0.8612044,0.00103761,0.0003875994,0.00001247242,0.0005277947,0.00002484908,0.1011292,0.00005079719,0.00117592,0.03125473],"study_design_scores_gemma":[0.007248417,0.004781768,0.8012455,0.000626676,0.00002590203,1.029078e-8,0.00004678512,0.001169836,0.1845198,0.00004317264,0.0001463344,0.0001457803],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9976023,0.0005948874,6.165329e-8,0.00008606479,0.0002304616,0.0006904871,0.00001118245,0.00004358076,0.0007409943],"genre_scores_gemma":[0.997394,0.001571045,0.00003935374,0.0001092941,0.0001167354,0.00006115453,0.000240279,0.00004032252,0.0004277986],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.08339055,"threshold_uncertainty_score":0.6294476,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null}]}